Medical observation and evaluation for suspected diseases and conditions

Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Z03 Cause of death: ICD-10 — Z03 2 out of 7 registries used, show all original rules.	96076
4. Check minimum number of events None	96076
5. Include endpoints None	96076
6. Filter based on genotype QC (FinnGen only)	92642

Control definitions (FinnGen only)

Control exclude: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Z[0-1]

NAME	Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI
CONTROL_EXCLUDE	Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z03
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z03
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Medical observation and evaluation for suspected diseases and conditions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Other transitory neonatal electrolyte and metabolic disturbances

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	92642	54591	38051
Unadjusted period prevalence (%)	18.57	19.36	17.43
Median age at first event (years)	55.03	51.55	60.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
46026: Matched controls
235344

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01DA01

ATC

[U] cefalexin

1.5

323.3

24508

102334

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.5

323.0

730

584

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.5

322.5

2624

5633

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

322.5

8540

28141

B01AC04

ATC

clopidogrel; oral

1.9

321.9

5197

14749

A02BA02

ATC

ranitidine; systemic

1.8

321.8

6500

19823

N05AX12

ATC

aripiprazole; systemic

3.2

321.5

1627

2671

L16

ICPC

Ankle symptom/complaint

2.0

317.0

4117

10805

C10AA01

ATC

simvastatin; oral

1.5

316.3

13773

51183

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

314.1

2798

6269

P76

ICPC

Depressive disorder

2.5

313.5

2487

5271

N06AB03

ATC

fluoxetine; oral

2.0

313.3

4244

11313

R74

ICPC

Upper respiratory infection acute

1.6

312.5

12397

45090

H03AA01

ATC

levothyroxine sodium; systemic

1.7

312.2

7768

25141

C10AA05

ATC

atorvastatin; oral

1.5

312.1

13883

51800

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

310.1

14336

53924

UJF92

NOMESCO Finland

Capsular endoscopy

5.4

309.4

819

785

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.3

307.8

1025

1226

N03AX12

ATC

[U] gabapentin; oral

2.7

307.7

6392

13416

C03CA01

ATC

furosemide; systemic

1.8

307.7

10848

33643

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

15.2

307.7

6058

2331

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

18.4

307.7

1874

542

R51.80

ICD-10 Finland

Headache

2.8

307.7

6887

13808

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

16252

44380

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

55.5

307.7

1794

172

A04

ICPC

Weakness/tiredness general

2.5

307.7

6209

13855

X58

ICD-10 Finland

Exposure to other specified factors

1.9

307.7

5469

15350

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

307.7

5832

16458

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

11724

36968

N05AH03

ATC

olanzapine; systemic

3.0

307.7

2617

4615

N03AE01

ATC

clonazepam; systemic

3.0

307.7

2149

3745

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

8546

25127

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

14618

45325

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.5

307.7

3299

6993

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.9

307.7

933

823

K30

ICD-10 Finland

Functional dyspepsia

2.3

307.7

4111

9699

G44.2

ICD-10 Finland

Tension-type headache

2.2

307.7

5041

12572

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

307.7

9236

27481

N03AX16

ATC

[U] pregabalin

2.6

307.7

9830

22077

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

307.7

3614

7746

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

22739

81931

N06AX16

ATC

venlafaxine; oral

2.6

307.7

5872

12751

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

108.6

307.7

2206

109

J01MA12

ATC

levofloxacin; systemic

2.0

307.7

7155

19624

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.3

307.7

676

477

M79.7

ICD-10 Finland

Fibromyalgia

4.1

307.7

1183

1519

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

307.7

4019

9655

Z00.8

ICD-10 Finland

Other general examinations

3.3

307.7

2732

4447

N05BA01

ATC

diazepam; systemic, rectal

2.1

307.7

4831

12341

XCK00

NOMESCO Finland

Perimetry

3.5

307.7

2149

3209

B01AB05

ATC

enoxaparin; parenteral

1.7

307.7

11150

36535

R01AD09

ATC

mometasone; nasal

1.6

307.7

17419

65971

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

307.7

5246

13371

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

307.7

5158

14016

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

81.0

307.7

6803

503

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.6

307.7

2209

3272

R05

ICPC

Cough

1.8

307.7

8703

27170

DFF00

NOMESCO Finland

Pure tone audiometry

4.0

307.7

3163

4242

R55

ICD-10 Finland

Syncope and collapse

2.1

307.7

3996

10101

XF402

NOMESCO Finland

ECG with work load test

3.2

307.7

4297

7284

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

307.7

7052

18264

SPAT1301

SPAT

No procedures

1.6

307.7

11194

38780

H02AB04

ATC

methylprednisolone; systemic

2.1

307.7

5345

14077

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

8167

24979

Z97.4

ICD-10 Finland

Presence of external hearing-aid

5.1

307.7

1366

1409

A01

ICPC

Pain general/multiple sites

2.7

307.7

3470

6896

M48.0

ICD-10 Finland

Spinal stenosis

2.1

307.7

3860

9802

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

307.7

4663

12209

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

307.7

8943

22986

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

307.7

8719

24903

J02AC01

ATC

fluconazole; systemic

1.6

307.7

14144

50012

J01CA04

ATC

amoxicillin; systemic

1.7

307.7

34901

153914

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

307.7

3416

7447

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

19.6

307.7

13350

4814

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

21380

85307

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

2.6

307.7

5113

10747

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

49.8

307.7

991

104

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

307.7

13868

47434

Z00.0

ICD-10 Finland

General medical examination

3.3

307.7

7378

12833

Z01.1

ICD-10 Finland

Examination of ears and hearing

8.2

307.7

5290

3682

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

307.7

7762

24343

ZX120

NOMESCO Finland

Intravenous

2.7

307.7

3514

6984

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

10343

28735

L15

ICPC

Knee symptom/complaint

1.7

307.7

8243

26183

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

21059

82019

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

307.7

18579

57615

XCH00

NOMESCO Finland

Eye pressure measurement

3.7

307.7

1485

2087

L17

ICPC

Foot/toe symptom/complaint

2.0

307.7

10968

32451

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.7

307.7

2137

2403

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

307.7

7458

22627

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

307.7

2414

4799

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

307.7

4300

11061

M01AH05

ATC

etoricoxib; oral

1.5

307.7

23838

97644

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.2

307.7

1377

1719

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

492.7

307.7

3392

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

307.7

11630

29196

N06AX11

ATC

mirtazapine; oral

2.1

307.7

13985

40778

M03BX02

ATC

tizanidine; oral

1.6

307.7

24452

98701

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

10952

27327

R50.9

ICD-10 Finland

Fever, unspecified

2.1

307.7

5906

15505

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

10175

30371

XG410

NOMESCO Finland

Flow-volume spirometry

5.4

307.7

1692

1652

S18

ICPC

Laceration/cut

2.0

307.7

18101

58067

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

307.7

9419

30419

SPAT1254

SPAT

Administration of medicine

2.1

307.7

5646

14606

R07.3

ICD-10 Finland

Other chest pain

2.4

307.7

3732

8422

Z01.0

ICD-10 Finland

Examination of eyes and vision

15.3

307.7

6529

2522

SPAT1229

SPAT

Assessment of need for aid

2.5

307.7

2489

5178

XCK10

NOMESCO Finland

Photography of fundus of eye

2.9

307.7

2955

5504

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

307.7

11747

35314

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

14944

52511

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.1

307.7

1876

2409

N03AX09

ATC

lamotrigine; oral

4.1

307.7

2128

2757

J01AA02

ATC

doxycycline; systemic

1.7

307.7

31441

132238

N30.0

ICD-10 Finland

Acute cystitis

1.9

307.7

5601

16127

L01

ICPC

Neck symptom/complaint

2.1

307.7

5704

15111

Z50.1

ICD-10 Finland

Other physical therapy

3.8

307.7

2221

3130

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

16743

53604

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

9101

22791

J01FF01

ATC

clindamycin; systemic

1.8

307.7

10602

32880

J01EA01

ATC

trimethoprim; systemic

1.7

307.7

9091

29778

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

27492

113790

J01MA02

ATC

ciprofloxacin; systemic

1.8

307.7

15342

50851

EBA00

NOMESCO Finland

Extraction of tooth

1.5

307.7

13873

51317

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

307.7

3562

7667

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

9072

28460

KMAK, ,

NOMESCO Finland

1.6

307.7

20155

78415

A29

ICPC

General symptom/complaint other

2.5

307.7

4987

10968

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

307.7

3232

7459

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

307.7

9743

30507

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

307.7

5762

11241

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

9441

30334

A28

ICPC

Limited function/disability NOS

2.1

307.7

5583

14752

ZXD05

NOMESCO Finland

Urgent procedure

1.6

307.7

11605

41246

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

5376

14896

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

307.7

30231

122850

D01

ICPC

Abdominal pain/cramps general

2.2

307.7

4469

11070

UKC02

NOMESCO Finland

Cystoscopy

2.2

307.7

5945

14812

N02AA05

ATC

oxycodone; systemic

2.1

307.7

6292

16336

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

23074

94528

T90

ICPC

Diabetes non-insulin dependent

1.8

307.7

7976

24699

UJF32

NOMESCO Finland

Coloscopy

2.8

307.7

10636

23164

N02AX02

ATC

tramadol; systemic, rectal

2.0

307.7

17869

55687

Z01.8

ICD-10 Finland

Other specified special examinations

9.5

307.7

9602

6348

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

307.7

1885

2701

XQ800

NOMESCO Finland

Prick test

5.0

307.7

2899

3125

RD211, ,

NOMESCO Finland

4.2

307.7

1294

1618

P03

ICPC

Feeling depressed

2.2

307.7

3906

9369

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

307.7

5672

14776

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

307.7

4462

11400

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.5

307.7

2235

3404

S06.0

ICD-10 Finland

Concussion

2.2

307.7

4182

10258

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

307.7

7361

18128

R60.0

ICD-10 Finland

Localized oedema

2.1

307.7

4162

10608

P01

ICPC

Feeling anxious/nervous/tense

2.1

307.7

4931

12762

J01DB01

ATC

cefalexin; oral

2.2

307.7

36311

149343

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

307.7

3888

8732

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.7

11764

37326

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18094

67000

N06AX21

ATC

duloxetine; oral

2.9

307.7

4796

9108

N06AB10

ATC

escitalopram; oral

2.0

307.7

8425

23456

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

307.7

1545

2356

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.8

307.7

2051

3796

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

3684

8322

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

9238

24877

N06AA09

ATC

amitriptyline; systemic

2.5

307.7

3274

6949

N03AG01

ATC

valproic acid; systemic, rectal

3.1

307.7

2451

4236

L28

ICPC

Limited function/disability (L)

2.4

307.7

6635

15207

-1, ,

NOMESCO Finland

1.7

307.7

13055

44639

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

307.7

3725

6297

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

307.7

10553

33419

R05

ICD-10 Finland

Cough

1.8

307.7

7544

23271

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

37.0

307.7

529

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

88.2

307.7

3627

228

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

307.7

6035

16502

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

13.3

307.7

576

224

N02BE01

ATC

paracetamol; systemic, rectal

2.4

307.7

38789

161645

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.4

307.7

2346

2323

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

307.7

5941

16426

R53

ICD-10 Finland

Malaise and fatigue

2.2

307.7

10127

27268

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

307.7

7520

21187

N05BA04

ATC

oxazepam; oral

2.1

307.7

10690

29303

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

307.7

3401

5775

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

22568

83994

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

43.7

307.7

4586

594

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

67.2

307.7

1463

115

R06AE07

ATC

cetirizine; oral

1.6

307.7

17329

63795

T89

ICPC

Diabetes insulin dependent

3.7

307.7

1423

2014

J01FA10

ATC

azithromycin; systemic

1.5

307.7

22981

94099

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.9

307.7

990

1047

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

5.6

307.7

2573

2479

H02AB06

ATC

prednisolone; systemic

2.0

307.7

19504

64276

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

4881

10838

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

307.7

4426

11588

ZY010

NOMESCO Finland

Hospital outpatient

3.1

307.7

1952

3353

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

13.3

307.7

514

200

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.4

307.7

2052

3182

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.8

307.7

1744

2438

L03

ICPC

Low back symptom/complaint

2.1

307.7

11042

31362

TAB00

NOMESCO Finland

Lumbar puncture

3.3

307.7

1683

2707

R29

ICPC

Respiratory symptom/complaint other

2.6

307.7

2531

5191

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

307.7

29612

122779

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

17692

61303

N02BF02

ATC

pregabalin; oral

2.8

307.7

2082

3917

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

14.2

307.7

1752

652

A10AB05

ATC

insulin aspart; parenteral

2.7

307.7

2751

5423

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.5

307.7

2522

3797

Z3231

NOMESCO Finland

Registered nurse

2.0

307.7

10612

30510

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

24204

97193

C07AB07

ATC

bisoprolol; oral

1.9

307.7

18670

62152

R13

ICD-10 Finland

Dysphagia

2.7

307.7

2375

4566

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

307.7

5155

12371

XA402

NOMESCO Finland

ENMG

15.1

307.7

1306

455

L08

ICPC

Shoulder symptom/complaint

1.8

307.7

7540

23125

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

307.7

3293

5902

M79.1

ICD-10 Finland

Myalgia

2.1

307.7

5424

14059

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

307.7

1845

2837

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

307.7

3342

7231

XF404

NOMESCO Finland

Ambulatory ECG

3.1

307.7

3507

6044

R52.2

ICD-10 Finland

Other chronic pain

4.2

307.7

1419

1778

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

83.5

307.7

8697

655

Z04.3

ICD-10 Finland

Examination and observation following other accident

75.2

307.7

823

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

307.7

3631

7715

M25.5

ICD-10 Finland

Pain in joint

2.0

307.7

12698

38288

N05AH04

ATC

quetiapine; oral

2.7

307.7

8201

17267

R00.2

ICD-10 Finland

Palpitations

2.5

307.7

2945

6172

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.2

307.7

3684

6185

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

307.7

18817

69464

C07AA05

ATC

propranolol; systemic

2.0

307.7

7868

22463

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.2

307.7

12850

25252

N05CF01

ATC

zopiclone; oral

1.8

307.7

12366

39050

R11

ICD-10 Finland

Nausea and vomiting

2.5

307.7

3357

7065

SPAT1263

SPAT

Sampling

1.6

307.7

16171

58372

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

307.7

4680

10110

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

307.7

15721

54444

R03DC03

ATC

montelukast; oral

1.9

307.7

6048

16983

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

307.7

7423

22061

A10AE04

ATC

insulin glargine; parenteral

2.5

307.7

3403

7410

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4710

11244

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

7.9

307.7

2360

1606

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.2

307.7

2737

4533

SPAT1216

SPAT

Assessment of functional ability

2.5

307.7

5475

12114

UJF30

NOMESCO Finland

Ileoscopy through colon

3.3

307.7

4043

6703

A02BC03

ATC

lansoprazole; oral

1.8

307.7

10168

32320

XA420

NOMESCO Finland

Extensive sleep examination

11.7

307.7

601

266

N06AX12

ATC

bupropion; oral

2.4

307.7

2782

6042

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

9286

28434

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

28915

101449

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

307.7

2633

5448

N06AB04

ATC

citalopram; systemic

2.1

307.7

8242

22040

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

22836

90945

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

6847

17088

DFF15

NOMESCO Finland

Speech audiometry

5.6

307.7

1355

1260

A02BC05

ATC

esomeprazole; systemic

1.9

307.7

16116

51364

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

307.7

5740

16471

P29

ICPC

Psychological sympt/compl other

2.6

307.7

2785

5754

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

16690

57592

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

307.7

17390

57091

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

22093

86487

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

307.7

3799

8953

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

6637

17958

XQ802

NOMESCO Finland

Epicutan test

6.0

307.7

1260

1107

S29

ICPC

Skin symptom/complaint other

1.9

307.7

6894

20043

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

307.7

8007

25609

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

18765

73751

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

307.7

11621

37767

E0000UV, ,

ATC

1.6

307.7

16127

58526

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

307.7

4241

9038

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

307.7

19961

78650

N06AB06

ATC

sertraline; oral

2.3

307.7

4490

10491

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

36.0

307.7

21296

5502

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

130.2

307.7

1431

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7156

19731

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

11520

40144

N17

ICPC

Vertigo/dizziness

2.1

307.7

4074

10524

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.3

8195

27011

R01AD08

ATC

fluticasone; nasal

1.6

307.2

10499

36850

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

305.5

2189

4403

A03

ICPC

Fever

1.8

305.1

6582

20442

N06AX26

ATC

vortioxetine; oral

2.4

302.9

2729

6144

N05CF02

ATC

zolpidem; oral

1.8

302.7

6023

18254

L12

ICPC

Hand/finger symptom/complaint

1.8

302.4

5745

17165

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

301.9

7481

24160

P20

ICPC

Memory disturbance

2.0

301.2

3935

10341

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

301.0

2050

4013

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

300.6

4552

12619

A06AD11

ATC

lactulose; oral

1.9

300.6

5075

14598

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.3

300.0

2956

6927

R96

ICPC

Asthma

2.2

299.5

3144

7571

D11

ICPC

Diarrhoea

2.0

299.3

4372

11966

AN1

Coronary angiography

2.1

298.7

3504

8831

Z03.0

ICD-10 Finland

Observation for suspected tuberculosis

79.1

297.5

292

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

296.9

3120

7516

R03BA05

ATC

fluticasone; inhalant

1.7

296.6

6642

20837

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

295.5

10942

39078

R21

ICPC

Throat symptom/complaint

1.7

294.9

8124

26973

A10BA02

ATC

metformin; oral

1.6

294.7

9615

33318

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

293.7

7022

22435

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

293.6

2466

5370

N05BA12

ATC

alprazolam; oral

2.1

292.3

3448

8706

N02BF01

ATC

gabapentin; oral

2.3

291.8

2646

5972

C01CA24

ATC

epinephrine; parenteral

2.5

290.4

2221

4618

SPAT1240

SPAT

Therapeutic discussion

2.0

290.1

3856

10193

N01

ICPC

Headache

2.0

289.1

4214

11518

L13

ICPC

Hip symptom/complaint

1.8

286.0

5568

16740

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

286.0

3657

9524

XG405

NOMESCO Finland

Education on PEF monitoring

8.0

286.0

554

360

M01AB05

ATC

diclofenac; systemic, rectal

1.4

285.8

25846

110471

L29

ICPC

Musculoskeletal sympt/complt other

2.2

285.3

2942

7026

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

284.6

1169

1657

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

283.9

8485

28733

Z01.9

ICD-10 Finland

Special examination, unspecified

2.8

282.9

1806

3409

N05AX08

ATC

risperidone; systemic

2.2

282.7

3125

7683

A10AB04

ATC

insulin lispro; parenteral

3.8

281.4

1090

1477

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

281.0

4178

11494

A98

ICPC

Health maint/preventive medicine

1.9

280.6

42451

202656

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.8

279.7

5052

14831

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.0

279.6

792

814

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

278.8

6949

22427

SPAT1360

SPAT

Extensive global examination

2.4

278.5

2380

5222

R35

ICD-10 Finland

Polyuria

2.5

278.4

2263

4848

U02

ICPC

Urinary frequency/urgency

1.9

278.2

4459

12586

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

276.7

1647

2986

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

276.5

3276

8279

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

276.2

13659

51816

SPAT1097

SPAT

Recording of ECG

1.9

276.2

4540

12921

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

274.1

2294

4983

D07AC01

ATC

betamethasone; topical

1.5

274.1

12931

48559

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

273.4

3514

9163

SPAT1252

SPAT

Overall medication plan or its review

2.6

273.1

1962

3948

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

272.7

3668

9728

A10AE05

ATC

insulin detemir; parenteral

2.7

272.4

1787

3424

SPAT1153

SPAT

Removal of sutures

1.6

271.7

10266

36715

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

271.2

2710

6381

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

271.0

2163

4591

CS494

NOMESCO Finland

Other visual field testing

4.8

270.7

808

874

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

270.3

2419

5422

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

270.1

6571

21048

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

270.0

3831

10359

A02BC01

ATC

omeprazole; systemic

1.6

268.5

9519

33533

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

268.1

2326

5138

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

268.0

3233

8225

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

267.8

8338

28470

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.8

267.3

1047

1431

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

266.9

2640

6188

R03BA02

ATC

budesonide; inhalant

1.7

266.7

6378

20327

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

266.4

8263

28183

SPAT1234

SPAT

Support of social functional capacity

2.7

266.2

1740

3327

M01AH01

ATC

celecoxib; oral

1.7

265.9

5920

18489

M01AC06

ATC

meloxicam; systemic, rectal

1.5

265.9

12357

46195

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

265.8

14130

54299

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

265.2

1536

2739

-69

ICPC

Other reason for encounter NEC

3.1

264.6

1419

2414

Z01.7

ICD-10 Finland

Laboratory examination

1.8

264.6

4875

14384

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

264.5

3860

10539

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

264.3

3286

8457

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

263.1

7481

24956

J01MA14

ATC

moxifloxacin; systemic

2.1

262.1

3047

7637

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

261.7

7796

26311

WX002

NOMESCO Finland

Sedation and analgesia

1.7

261.1

6337

20268

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.9

260.9

989

1317

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

260.8

4406

12640

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.8

259.6

1008

1368

XKD00

NOMESCO Finland

Uroflowmetry

1.8

259.0

5173

15641

J01FA06

ATC

roxithromycin; oral

1.5

258.1

14325

55444

C08CA01

ATC

amlodipine; oral

1.5

257.9

12518

47161

SFA30

NOMESCO Finland

Three-surface restoration

1.5

257.8

15212

59580

M54.2

ICD-10 Finland

Cervicalgia

2.2

257.7

2668

6375

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

257.6

3838

10550

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.3

255.1

867

1055

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

255.0

3127

8001

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.3

254.9

2465

5718

SPAT1359

SPAT

Use of symptom diary

4.4

254.2

826

966

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

254.0

1497

2697

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

253.1

2461

5722

H25.8

ICD-10 Finland

Other senile cataract

2.0

252.6

3271

8544

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

251.2

2819

6962

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

250.8

1643

3144

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.4

250.7

826

978

R03BA08

ATC

ciclesonide; inhalant

2.1

250.1

2859

7114

A46

ICD-10 Finland

Erysipelas

1.8

250.0

4903

14732

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

249.1

15191

59772

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

248.8

1832

3731

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

248.7

2839

7060

A11

ICPC

Chest pain NOS

2.2

248.6

2594

6216

H02AB09

ATC

hydrocortisone; systemic

4.1

248.6

885

1120

F34.1

ICD-10 Finland

Dysthymia

3.1

248.3

1288

2145

H02AB07

ATC

prednisone; oral

1.8

248.0

4730

14089

R06AX22

ATC

ebastine; oral

1.7

247.8

6007

19182

127

Kela drug reimbursment

Transplant complication

5.9

247.2

604

530

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

244.1

3821

10674

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

243.5

3437

9261

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

243.2

4422

12973

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

243.1

1815

3722

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

243.1

5534

17359

A02BC04

ATC

rabeprazole; oral

2.1

242.9

2858

7191

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

242.6

4556

13501

Z2445

NOMESCO Finland

Psychologist

3.0

242.3

1368

2401

R03BB04

ATC

tiotropium bromide; inhalant

2.0

241.0

3293

8768

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.2

241.0

2659

6519

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

241.0

2497

5964

K29

ICPC

Cardiovascular sympt/complt other

2.9

240.9

1414

2540

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

238.5

2540

6136

N06BA04

ATC

methylphenidate; oral

3.1

238.4

1260

2123

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

238.3

3971

11323

M01AX17

ATC

nimesulide; oral

1.6

237.8

7703

26464

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.1

237.6

560

471

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.2

237.6

817

1004

J01FA09

ATC

clarithromycin; systemic

1.5

237.4

11293

42228

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

237.3

2162

4879

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

237.1

6709

22291

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

236.7

7961

27592

G04BD12

ATC

mirabegron; oral

1.9

235.3

3431

9348

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.1

234.2

830

1046

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

233.2

2492

6027

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

231.9

2124

4804

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

231.9

2068

4621

A10AE06

ATC

insulin degludec; parenteral

3.2

231.6

1163

1896

B01AA03

ATC

warfarin; systemic

1.6

230.9

6278

20635

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.3

230.7

2244

5213

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.5

230.2

993

1458

D02

ICPC

Abdominal pain epigastric

2.4

229.9

2006

4437

H04AA01

ATC

glucagon; nasal, parenteral

4.1

229.8

825

1051

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

229.8

1669

3373

A10AB01

ATC

insulin (human); parenteral

3.2

229.7

1177

1944

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

229.6

7374

25257

C09CA06

ATC

candesartan; oral

1.6

229.6

8049

28143

E000001, ,

ATC

1.6

228.4

7098

24117

Z2446

NOMESCO Finland

Social worker

2.2

228.4

2259

5286

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

227.9

3174

8504

R5120

NOMESCO Finland

Preparation of an aid

4.2

227.7

776

946

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.9

227.0

1353

2452

L14

ICPC

Leg/thigh symptom/complaint

2.1

226.7

2595

6453

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

226.4

2777

7095

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

225.4

9170

33124

L04AA06

ATC

mycophenolic acid; systemic

4.6

225.3

694

773

J05AB01

ATC

aciclovir; systemic

1.6

225.0

7349

25260

A05

ICPC

Feeling ill

2.2

225.0

2294

5438

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

224.6

6901

23373

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

224.3

3045

8081

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

224.0

9140

33030

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

223.7

7170

24531

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

223.3

3464

9635

L04AX01

ATC

azathioprine; systemic

2.7

223.1

1498

2903

Y96.9

ICD-10 Finland

Unspecified type of accident

4.5

223.1

716

828

S97

ICPC

Chronic ulcer skin

2.4

221.8

1890

4133

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

221.5

4785

14760

N04BC05

ATC

pramipexole; oral

2.2

221.5

2345

5647

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.9

221.0

825

1085

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

220.1

1491

2903

E66.8

ICD-10 Finland

Other obesity

2.4

219.3

1869

4087

SPAT1104

SPAT

Monitoring of emergency patient

2.3

219.1

2151

5015

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

218.7

2484

6155

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

217.5

2014

4575

SPAT1211

SPAT

Application of soft bandage

2.0

217.5

2969

7892

R83

ICPC

Respiratory infection other

1.5

216.9

9738

35870

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

216.6

4499

13714

H29

ICPC

Ear symptom/complaint other

1.9

216.4

3613

10294

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.1

216.2

1141

1920

G04CA02

ATC

tamsulosin; oral

1.5

216.1

7968

28131

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

216.0

3009

8057

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

15.9

215.3

291

L02

ICPC

Back symptom/complaint

1.9

215.1

3438

9654

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

214.5

12475

48326

R31

ICD-10 Finland

Unspecified haematuria

1.9

214.1

3358

9370

A10AC01

ATC

insulin (human); parenteral

2.1

213.8

2492

6238

H01

ICPC

Ear pain/earache

1.8

213.5

3944

11603

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

13.6

213.2

307

116

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

213.1

1603

3297

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

212.9

4689

14534

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

211.7

9543

35154

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.8

211.4

1348

2538

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

211.2

1757

3797

A10BH01

ATC

sitagliptin; oral

2.0

211.1

2843

7517

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.9

210.3

1227

2195

K03.66

ICD-10 Finland

Tooth plaque

2.1

210.2

2519

6373

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

209.7

1831

4048

SPAT1262

SPAT

Handing over of treatment supplies

1.6

209.5

5615

18348

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

209.1

3211

8893

DAX08

NOMESCO Finland

Fitting of hearing aid

2.8

208.9

1319

2470

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

208.8

3921

11589

R01AD58

ATC

fluticasone, combinations; nasal

1.5

208.8

8640

31250

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

208.8

1570

3228

R01AD12

ATC

fluticasone furoate; nasal

1.4

208.2

11392

43577

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

208.1

27510

122205

J45.8

ICD-10 Finland

Mixed asthma

3.2

207.5

1020

1639

D06

ICPC

Abdominal pain localized other

2.0

206.8

2825

7507

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

206.1

2409

6034

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

206.0

3396

9629

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.8

205.7

1265

2333

C10AA07

ATC

rosuvastatin; oral

1.5

205.6

10031

37510

ZXA00

NOMESCO Finland

Right side

1.5

205.5

8428

30414

D19

ICPC

Teeth/gum symptom/complaint

1.5

205.3

10055

37628

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

205.2

1977

4569

K22

ICPC

Risk factor cardiovascular disease

2.4

205.1

1730

3763

N06AX22

ATC

agomelatine; oral

3.7

205.0

842

1192

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

204.7

10179

38204

C09AA05

ATC

ramipril; oral

1.5

204.5

8034

28720

F61.0

ICD-10 Finland

Mixed personality disorders

4.6

204.0

641

727

P74

ICPC

Anxiety disorder/anxiety state

2.5

203.6

1537

3166

P99

ICPC

Psychological disorders other

3.2

203.0

1036

1706

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

202.7

1371

2666

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

202.7

9888

36958

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

202.5

6340

21518

A99

ICPC

Disease/condition unspecnature/site

1.9

202.3

3033

8327

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

202.1

1077

1823

SPAT1172

SPAT

Guidance concerning hydration

3.7

201.8

808

1122

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

201.7

2430

6158

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

201.5

10048

37711

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

201.4

2021

4753

A06AC51

ATC

ispaghula, combinations; oral

2.5

201.1

1558

3251

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

201.1

1999

4683

R06AX27

ATC

desloratadine; oral

1.5

200.5

10125

38089

C03DA01

ATC

spironolactone; oral

1.8

200.5

3801

11261

H13

ICPC

Plugged feeling ear

1.6

200.4

5918

19798

R06AE09

ATC

levocetirizine; oral

1.7

199.9

4975

15929

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

199.4

1309

2504

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

198.9

2277

5655

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

198.9

12729

50033

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

198.7

4522

14129

R01AD11

ATC

triamcinolone; nasal

1.9

197.3

2836

7671

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.3

195.9

1830

4170

D07AD01

ATC

clobetasol; topical

1.6

195.9

5352

17552

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.2

194.9

667

816

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.0

194.4

712

922

XA800

NOMESCO Finland

Neuropsychological investigation

2.6

193.8

1371

2730

K07.60

ICD-10 Finland

Snapping jaw

2.4

193.8

1672

3674

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.2

193.8

667

820

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

193.4

2363

6019

J01DA09

ATC

[U] cefadroxil

1.5

192.6

9578

35878

C07AB02

ATC

metoprolol; systemic

1.6

192.3

6508

22470

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

191.7

1052

1813

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.5

190.9

495

464

S21

ICPC

Skin texture symptom/complaint

1.7

190.4

4577

14507

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

190.4

1997

4784

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

190.4

3250

9311

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

190.0

2590

6871

N05BE01

ATC

buspirone; oral

3.1

189.5

1012

1715

SDA03

NOMESCO Finland

Periodontal treatment

1.4

188.9

14445

58426

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

188.7

1834

4252

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

188.5

3041

8552

R03AC03

ATC

terbutaline; inhalant

1.7

187.3

4661

14906

N03AX11

ATC

topiramate; oral

3.4

186.3

838

1267

J01CA08

ATC

pivmecillinam; oral

1.4

186.3

13142

52406

A07AA02

ATC

nystatin; oral

2.3

186.3

1737

3954

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

184.5

1525

3283

R06.5

ICD-10 Finland

Mouth breathing

1.9

183.9

2962

8323

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

182.1

1976

4799

WX722

NOMESCO Finland

PEEP

2.4

180.6

1490

3204

N06AB05

ATC

paroxetine; oral

2.2

180.5

1940

4693

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.1

180.4

2195

5578

C10AX09

ATC

ezetimibe; oral

1.7

180.0

4586

14749

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

179.4

2461

6540

F29

ICPC

Eye symptom/complaint other

1.8

179.2

3043

8697

M02AA10

ATC

ketoprofen; topical

1.6

179.1

5104

16888

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

179.1

2990

8499

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.0

178.5

2384

6274

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

178.1

19133

81437

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

177.9

2163

5495

K59.0

ICD-10 Finland

Constipation

2.2

177.9

1827

4336

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.7

177.5

544

603

N05AN01

ATC

lithium; oral

3.3

177.2

839

1314

ZXA05

NOMESCO Finland

Left side

1.5

177.1

7726

28129

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

176.8

886

1441

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

176.8

9300

35125

GX2C5

NOMESCO Finland

Short-lasting oximetry

15.4

176.6

242

N05AA02

ATC

levomepromazine; systemic

2.5

176.6

1379

2887

Z3226

NOMESCO Finland

Physiotherapist

1.6

175.7

5817

19945

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

4.0

175.7

640

825

M04AA01

ATC

allopurinol; systemic

1.7

175.2

4153

13095

K08.80

ICD-10 Finland

Toothache NOS

1.9

175.2

2935

8349

C01DA14

ATC

isosorbide mononitrate; oral

1.6

174.8

4832

15861

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

174.8

37785

178952

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

174.5

1441

3100

UJD02

NOMESCO Finland

Gastroscopy

2.4

173.8

1416

3026

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

173.4

1193

2340

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

173.3

3520

10624

H02

ICPC

Hearing complaint

1.7

173.3

3770

11606

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

35.7

173.0

188

U07

ICPC

Urine symptom/complaint other

2.0

172.9

2246

5849

WX320

NOMESCO Finland

Spinalanesthesy

1.5

172.7

7890

28977

H3600, E103,

ICD-10 Finland

6.8

172.4

374

284

P06

ICPC

Sleep disturbance

1.7

172.4

3865

11999

N07BB01

ATC

disulfiram; oral

2.3

172.4

1521

3375

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.2

172.3

589

720

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

171.4

12575

50320

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

171.4

2054

5188

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

171.3

1083

2028

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

3.1

171.3

897

1501

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

171.1

1969

4894

N06AX05

ATC

trazodone; oral

3.3

171.0

827

1314

SFA00

NOMESCO Finland

Small restoration

1.6

170.6

4475

14489

H53.2

ICD-10 Finland

Diplopia

2.9

170.3

1004

1806

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

170.1

938

1621

F41.00

ICD-10 Finland

Moderate panic disorder

4.2

169.4

581

712

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

169.4

9624

36825

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

169.3

4480

14535

M02AA07

ATC

piroxicam; topical

1.4

169.0

11868

47121

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

168.3

658

897

XG466

NOMESCO Finland

Sleep oxymetry

2.9

168.3

966

1710

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

168.2

1013

1845

SPAT1260

SPAT

Consultation of another employee

1.6

167.3

5628

19349

K80

ICPC

Cardiac arrhythmia NOS

1.9

167.3

2398

6469

R33

ICD-10 Finland

Retention of urine

1.9

167.0

2524

6935

Z29

ICPC

Social problem NOS

3.4

167.0

745

1120

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

166.9

1662

3891

C08CA13

ATC

lercanidipine; oral

1.7

166.4

4139

13210

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.1

166.0

884

1495

A08

ICPC

Swelling

2.3

165.9

1482

3307

Z94.0

ICD-10 Finland

Kidney transplant status

5.8

165.6

411

367

M01AH02

ATC

rofecoxib; oral

1.7

165.6

3788

11819

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

165.2

1528

3463

RF410, ,

NOMESCO Finland

6.7

164.5

362

280

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

164.2

734

1105

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.7

163.9

659

918

C10AC01

ATC

colestyramine; oral

3.1

163.8

849

1411

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

163.8

13923

56956

K04

ICPC

Palpitations/awareness of heart

2.2

163.5

1605

3734

N05CD07

ATC

temazepam; oral

1.7

163.1

3732

11643

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

163.1

2000

5094

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

162.9

1763

4274

R51

ICD-10 Finland

Headache

2.1

162.8

1910

4782

N03AF02

ATC

oxcarbazepine; oral

2.7

162.6

1092

2114

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

162.2

1364

2959

A10AA01, ,

ATC

3.2

162.0

799

1286

L04

ICPC

Chest symptom/complaint

2.1

161.9

1912

4800

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

161.6

2089

5427

S04

ICPC

Lump/swelling localized

1.7

161.4

3327

10076

Z11

ICPC

Compliance/being ill problem

9.0

161.3

288

165

M35.7

ICD-10 Finland

Hypermobility syndrome

4.6

160.9

504

570

D07AC13

ATC

mometasone; topical

1.4

160.8

9796

37900

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

160.4

3898

12358

L86

ICPC

Back syndrome with radiating pain

2.1

160.3

1842

4574

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.3

160.0

1468

3315

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

159.7

1704

4106

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

159.2

1123

2231

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

158.6

1357

2967

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

158.5

603

805

G04BD08

ATC

solifenacin; oral

2.1

158.0

1832

4565

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.3

157.7

753

1186

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

157.6

1325

2873

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.4

157.6

513

601

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

157.4

3061

9111

-50

ICPC

Medication/prescr/renewal

2.5

157.4

1231

2578

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.1

157.2

811

1344

B01AF02

ATC

apixaban; oral

1.7

156.9

3549

11032

FN1AD

NOMESCO Finland

CT of coronary arteries

4.0

156.6

569

732

-34

ICPC

Blood test

2.9

156.3

913

1633

M54.8

ICD-10 Finland

Other dorsalgia

2.3

155.9

1438

3254

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

155.0

1591

3772

Z08

ICPC

Social welfare problem

4.8

155.0

462

499

R12

ICD-10 Finland

Heartburn

1.9

154.9

2522

7099

EB1VA, ,

NOMESCO Finland

1.6

154.9

4063

13135

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.4

154.9

409

391

L11

ICPC

Wrist symptom/complaint

1.8

154.7

2774

8054

U01

ICPC

Dysuria/painful urination

1.9

154.6

2311

6322

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.6

154.6

1127

2278

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

154.5

2216

5975

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.6

154.5

392

359

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

154.3

2084

5500

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

154.3

1455

3325

SPAT1255

SPAT

Intravenous administration of medicine

2.0

154.3

2033

5318

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

154.1

1614

3859

WZC30

NOMESCO Finland

Teaching

1.6

153.9

4633

15497

L04AD02

ATC

tacrolimus; systemic

5.8

153.8

378

334

XCW10

NOMESCO Finland

Assessment of vision

5.3

153.4

412

401

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

3.2

152.9

777

1275

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

152.9

1655

4011

S76

ICPC

Skin infection other

2.2

152.9

1650

3994

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

152.6

867

1525

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.8

152.2

946

1754

SPAT1312

SPAT

General health counselling

1.4

152.2

11066

44043

B01AF01

ATC

rivaroxaban; oral

1.7

151.7

3555

11153

N06AX03

ATC

mianserin; oral

2.3

151.7

1417

3225

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.9

151.6

439

461

WX892

NOMESCO Finland

Monitored bed care

1.9

151.5

2347

6497

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

151.4

2315

6380

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

151.3

6780

24730

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

151.0

2879

8514

R03BA01

ATC

beclometasone; inhalant

1.6

150.6

4385

14545

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

3.7

150.2

601

834

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.2

150.0

1588

3813

R07.0

ICD-10 Finland

Pain in throat

1.9

149.8

2360

6570

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

149.6

7790

29241

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

149.5

3461

10821

W19

ICD-10 Finland

Unspecified fall

1.7

149.4

3176

9696

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

12.0

149.1

227

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

149.0

1743

4357

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

149.0

8048

30412

K07

ICPC

Swollen ankles/oedema

2.4

148.7

1253

2720

N05AF03

ATC

chlorprothixene; systemic

2.9

148.5

880

1587

S80.0

ICD-10 Finland

Contusion of knee

1.9

148.5

2400

6737

M54.1

ICD-10 Finland

Radiculopathy

2.4

148.4

1244

2693

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.4

148.4

667

1008

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.3

148.3

400

391

J45

ICD-10 Finland

Asthma

1.7

148.2

3294

10182

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

148.2

3983

12949

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

148.2

1059

2118

H57.1

ICD-10 Finland

Ocular pain

2.5

148.0

1161

2434

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

148.0

2176

5916

R06.4

ICD-10 Finland

Hyperventilation

3.9

146.9

556

739

N03AF01

ATC

carbamazepine; oral, rectal

2.2

146.5

1567

3778

TK800

NOMESCO Finland

Hemodialysis

3.3

146.5

695

1090

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

146.3

1181

2511

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

146.2

2627

7627

XF640, ,

NOMESCO Finland

2.8

146.1

883

1611

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

11.9

146.0

223

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.7

145.9

944

1790

L04AX03

ATC

methotrexate; systemic

1.7

145.8

2960

8916

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.4

145.6

472

551

SGA01

NOMESCO Finland

Emergency treatment

1.5

145.5

5715

20275

207

Kela drug reimbursment

Chronic arrhythmias

1.6

145.5

4408

14756

ACC51

NOMESCO Finland

Release of median nerve

1.9

145.4

2191

6007

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.6

145.3

320

248

P25

ICPC

Phase of life problem adult

2.2

145.2

1409

3260

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.2

145.2

1484

3511

R1250

NOMESCO Finland

Evaluation of functional capability

3.3

145.1

676

1047

P01BA02

ATC

hydroxychloroquine; oral

1.8

145.0

2425

6882

R4110

NOMESCO Finland

Physiotherapy

1.4

144.8

9023

34946

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

144.5

808

1408

N29

ICPC

Neurological sympt/complt other

3.5

144.4

637

950

J30.3

ICD-10 Finland

Other allergic rhinitis

2.5

144.2

1136

2387

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

144.1

728

1190

U29

ICPC

Urinary symptom/complaint other

2.8

144.0

898

1668

D82

ICPC

Teeth/gum disease

1.3

143.9

13746

56959

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

143.9

10604

42224

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

143.9

1602

3926

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

143.7

3347

10476

R51.81

ICD-10 Finland

Facial pain NOS

3.2

143.7

722

1176

R5110, ,

SPAT

2.1

143.6

1724

4352

S10

ICPC

Boil/carbuncle

2.0

143.1

1833

4742

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.5

142.9

1094

2266

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

142.3

1294

2909

L05

ICPC

Flank/axilla symptom/complaint

2.0

142.1

1823

4719

C05AA08

ATC

fluocortolone; rectal, topical

1.6

141.9

4201

13980

SPAT1167

SPAT

Insertion of urinary catheter

2.7

141.8

954

1848

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

141.4

2746

8161

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

140.2

716

1179

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

140.1

578

821

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

140.0

4087

13553

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

139.9

2482

7175

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

139.6

743

1256

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

139.2

1539

3760

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.3

139.0

646

999

R4110, ,

SPAT

1.8

139.0

2337

6642

U05

ICPC

Urination problems other

2.2

138.9

1436

3413

N76.0

ICD-10 Finland

Acute vaginitis

2.0

138.6

1879

4962

M54.3

ICD-10 Finland

Sciatica

2.0

138.4

1793

4658

M05BA04

ATC

alendronic acid; oral

1.9

138.3

2257

6353

N28

ICPC

Limited function/disability (N)

3.8

138.2

533

719

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

138.0

6610

24380

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

138.0

2222

6227

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

137.9

2673

7938

A11CC03

ATC

alfacalcidol; systemic

3.0

137.5

737

1251

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.4

137.5

1111

2363

N06AA12

ATC

doxepin; systemic

2.1

137.2

1482

3587

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.4

137.1

610

915

N27

ICPC

Fear of neurological disease other

4.1

137.1

481

601

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.8

137.0

295

222

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.3

137.0

453

538

U71

ICPC

Cystitis/urinary infection other

2.0

136.8

1877

4978

A03FA02

ATC

cisapride; oral, rectal

1.9

136.8

2246

6334

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

136.7

8755

34017

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.8

136.7

831

1521

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

136.4

1683

4292

SPAT1053

SPAT

Memory test

1.6

135.8

3686

12001

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

135.7

1441

3463

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.7

135.5

874

1654

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

135.3

1649

4186

C09CA01

ATC

losartan; oral

1.4

135.1

7766

29610

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

135.0

11963

48919

T74.1

ICD-10 Finland

Physical abuse

3.2

134.8

667

1076

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

134.4

982

1986

D12

ICPC

Constipation

2.5

134.3

1038

2160

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.8

134.2

853

1601

K92.1

ICD-10 Finland

Melaena

2.1

134.2

1613

4072

RF420, ,

NOMESCO Finland

4.9

133.9

388

408

A97

ICPC

No disease

1.5

133.6

5970

21712

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.8

133.6

805

1466

-42

ICPC

Electrical tracing

4.7

133.2

407

450

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.9

133.1

385

404

G04CA01

ATC

alfuzosin; oral

1.6

133.0

3884

12872

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

132.8

647

1033

M01AX05

ATC

glucosamine; oral

1.5

132.8

5179

18319

SAA04

NOMESCO Finland

Special examination of mouth

2.0

132.6

1721

4472

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.1

132.6

278

202

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.9

132.6

767

1364

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.0

132.5

279

204

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

9.4

131.8

228

124

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

131.8

910

1787

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

131.8

1957

5335

R04

ICPC

Breathing problem other

2.4

131.1

1112

2420

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

130.7

1569

3959

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

130.6

1428

3472

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

130.6

3872

12876

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.5

130.5

1035

2181

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.4

130.5

1098

2381

R30.0

ICD-10 Finland

Dysuria

2.2

130.4

1314

3089

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

130.1

1669

4318

S06

ICPC

Rash localized

2.0

130.1

1702

4436

D09

ICPC

Nausea

2.1

130.0

1510

3762

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

18.2

129.8

167

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.8

129.4

318

281

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

129.2

3032

9499

A10BK03

ATC

empagliflozin; oral

1.7

129.1

2679

8112

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

128.7

1577

4010

Z51.6

ICD-10 Finland

Desensitization to allergens

4.1

128.6

452

566

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

128.5

3963

13299

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

128.3

1696

4437

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.9

128.1

311

271

Z03.4

ICD-10 Finland

Observation for suspected myocardial infarction

60.1

128.0

129

K78

ICPC

Atrial fibrillation/flutter

1.9

127.8

2046

5720

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.3

127.7

341

330

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

127.4

1066

2305

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

218.8

127.3

171

J05AB11

ATC

valaciclovir; oral

1.5

127.2

4360

14987

A10BK01

ATC

dapagliflozin; oral

1.9

127.2

2020

5632

J01MA01

ATC

ofloxacin; systemic

1.7

126.9

2580

7764

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

6.5

126.6

285

227

H3603, E103,

ICD-10 Finland

5.5

126.4

325

302

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.2

126.4

431

526

J46

ICD-10 Finland

Status asthmaticus

2.7

126.3

816

1546

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

126.0

1350

3255

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

126.0

3098

9826

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

125.3

2116

6018

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

125.3

1042

2247

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.0

125.2

1655

4329

Z72.2

ICD-10 Finland

Drug use

7.6

125.2

250

170

J20

ICD-10 Finland

Acute bronchitis

1.6

125.1

3200

10252

S22.3

ICD-10 Finland

Fracture of rib

1.8

125.0

2148

6143

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

124.9

2904

9072

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

124.6

1083

2384

K04.08

ICD-10 Finland

Other specified pulpit

1.7

124.4

2507

7524

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.7

124.3

832

1607

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

123.9

2031

5720

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

123.9

1630

4256

N07CA01

ATC

betahistine; oral

1.9

123.8

2014

5658

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

123.8

1120

2511

H93.1

ICD-10 Finland

Tinnitus

1.9

123.7

1960

5459

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

123.7

2269

6621

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

123.5

1924

5329

B02AA02

ATC

tranexamic acid; systemic

1.5

123.2

4358

15080

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.4

123.1

1031

2230

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

4.6

122.9

379

423

A01AB09

ATC

miconazole; local oral

1.7

122.8

2566

7782

L50.0

ICD-10 Finland

Allergic urticaria

2.7

122.6

817

1574

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.1

122.6

438

556

R06.2

ICD-10 Finland

Wheezing

2.1

122.5

1350

3293

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.5

122.2

385

438

A07EA06

ATC

budesonide; oral, local oral

2.3

122.1

1122

2533

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.7

122.0

798

1522

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

121.8

4676

16464

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.3

121.6

570

887

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

121.4

2627

8044

XA400

NOMESCO Finland

EEG

8.1

121.4

232

148

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

121.0

3611

12015

P15

ICPC

Chronic alcohol abuse

2.5

121.0

943

1970

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

120.6

2914

9195

D02AE01

ATC

carbamide; topical

1.9

120.5

1932

5402

M10.9

ICD-10 Finland

Gout, unspecified

1.8

120.1

1989

5619

F32.8

ICD-10 Finland

Other depressive episodes

3.5

119.9

523

774

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

119.7

2842

8926

R52.1

ICD-10 Finland

Chronic intractable pain

5.6

119.6

305

281

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

119.5

5295

19190

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

119.4

615

1018

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

119.4

13742

58076

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.3

119.4

224

139

R06AX13

ATC

loratadine; oral

1.5

119.3

4869

17356

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

119.3

428

545

RD210, ,

NOMESCO Finland

3.4

119.2

537

813

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.7

119.1

802

1554

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

119.0

1311

3197

T82

ICPC

Obesity

2.2

119.0

1259

3020

G43.3

ICD-10 Finland

Complicated migraine

3.4

118.9

545

835

L20.0

ICD-10 Finland

Besnier prurigo

1.8

118.8

2276

6727

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

118.8

1731

4686

S01BC05

ATC

ketorolac; ophthalmic

2.2

118.8

1164

2703

SPAT1058

SPAT

PEF monitoring instruction

1.8

118.7

2244

6606

A12AA04

ATC

calcium carbonate; oral

3.6

118.1

498

719

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

117.9

2005

5713

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.3

117.8

1063

2380

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

117.8

7878

30727

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

117.8

1092

2475

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

3.7

117.8

467

644

WX872

NOMESCO Finland

Intensive care

2.0

117.7

1460

3729

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

117.5

2453

7434

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

7.4

117.4

239

167

JAH01

NOMESCO Finland

Laparoscopy

2.2

117.2

1249

3004

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

117.0

1023

2258

F32

ICD-10 Finland

Depressive episode

1.9

116.9

1782

4899

A04AA01

ATC

ondansetron; systemic, rectal

1.7

116.8

2351

7050

D10

ICPC

Vomiting

1.8

116.8

2002

5718

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

116.8

2073

5986

U04

ICPC

Incontinence urine

2.1

116.7

1355

3374

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

116.5

3247

10624

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.9

116.1

283

248

JN4AD

NOMESCO Finland

Body CT examination

1.6

116.1

2903

9241

WX882

NOMESCO Finland

High dependency care

2.6

115.9

844

1704

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

115.6

1203

2865

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

115.4

791

1547

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

115.1

1749

4802

P19

ICPC

Drug abuse

4.4

114.8

376

443

J01AA04

ATC

lymecycline; systemic

1.5

114.8

4456

15713

L76

ICPC

Fracture: other

2.6

114.8

804

1591

A23

ICPC

Risk factor NOS

1.6

114.7

2850

9055

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

114.6

718

1337

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

114.6

11026

45413

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

114.3

3328

11003

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

114.1

9667

39089

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

114.0

2551

7881

H36.01

ICD-10 Finland

Diabetic maculopathy

4.5

113.8

364

420

UJH02

NOMESCO Finland

Anoscopy

2.2

113.8

1139

2669

H92.0

ICD-10 Finland

Otalgia

1.9

113.8

1845

5176

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

113.8

944

2033

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

113.7

1308

3244

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

113.7

1935

5513

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

113.6

1992

5729

R03AC13

ATC

formoterol; inhalant

2.0

113.6

1475

3831

R04.2

ICD-10 Finland

Haemoptysis

2.4

113.6

987

2172

R09

ICPC

Sinus symptom/complaint

1.7

113.5

2416

7360

L04AD01

ATC

ciclosporin; systemic

3.2

113.3

562

908

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

113.3

998

2210

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

113.3

593

992

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.9

113.0

643

1132

Z49.2

ICD-10 Finland

Other dialysis

6.1

113.0

265

222

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.4

113.0

295

279

GX1K5

NOMESCO Finland

Diffusion capacity

13.6

112.8

162

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

112.6

1305

3246

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.9

112.6

659

1180

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

112.4

761

1479

N39.3

ICD-10 Finland

Stress incontinence

1.9

112.1

1696

4649

A10BH05

ATC

linagliptin; oral

2.1

112.0

1346

3396

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

111.9

735

1405

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

111.8

1627

4401

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

111.8

2153

6372

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

111.7

1697

4658

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

111.7

1935

5544

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

111.6

1121

2630

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

111.5

2335

7081

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.4

110.7

506

774

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

110.4

2223

6665

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.4

110.4

493

742

N89

ICPC

Migraine

2.2

109.2

1114

2631

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

109.1

919

1993

ZXA10

NOMESCO Finland

Bilateral

1.4

109.1

5407

19991

L50.8

ICD-10 Finland

Other urticaria

3.3

109.0

514

803

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

109.0

944

2074

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

109.0

1644

4502

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

108.9

871

1843

A02BA04

ATC

nizatidine; systemic

1.7

108.8

2160

6448

N06AG02

ATC

moclobemide; oral

2.1

108.8

1208

2954

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

108.8

1079

2518

R04.0

ICD-10 Finland

Epistaxis

1.8

108.6

2146

6398

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

108.4

5748

21515

S01

ICPC

Pain/tenderness of skin

2.0

108.2

1325

3367

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

108.2

1650

4535

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

107.9

779

1566

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

107.8

792

1606

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.3

107.8

977

2192

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

6.4

107.7

244

196

B02.9

ICD-10 Finland

Zoster without complication

1.8

107.6

1773

4998

R81

ICPC

Pneumonia

2.2

107.5

1055

2451

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.4

107.2

899

1946

H3601, E103,

ICD-10 Finland

5.6

107.0

270

246

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

106.5

513

813

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.9

106.4

609

1076

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

106.4

3109

10280

K90

ICPC

Stroke/cerebrovascular accident

2.6

106.4

746

1477

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.1

106.4

250

210

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

106.3

1123

2691

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

106.0

526

850

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

106.0

6800

26289

J02AC02

ATC

itraconazole; systemic

1.4

106.0

5370

19927

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.9

106.0

392

512

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.6

105.7

437

622

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

105.6

1069

2516

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

105.3

11804

49524

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

105.1

1377

3588

R52.0

ICD-10 Finland

Acute pain

2.3

105.0

993

2270

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

105.0

1490

3995

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

104.9

4950

18123

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

104.9

3164

10539

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.1

104.5

1153

2812

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.5

104.5

193

117

L84

ICPC

Back syndrome without radiat pain

2.0

104.5

1342

3471

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

104.4

1776

5057

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.8

104.4

256

226

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.3

104.3

930

2071

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

104.2

1460

3896

R10.0

ICD-10 Finland

Acute abdomen

2.2

103.9

1006

2323

I20.09

ICD-10 Finland

Unstable angina

1.9

103.9

1590

4374

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

103.8

1415

3740

M01AB55

ATC

diclofenac, combinations; oral

1.8

103.7

1807

5185

S01.0

ICD-10 Finland

Open wound of scalp

1.7

103.5

2461

7723

F06.7

ICD-10 Finland

Mild cognitive disorder

2.6

103.5

744

1492

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.8

103.4

640

1184

F93.89

ICD-10 Finland

Other childhood emotional disorders

5.6

103.3

263

242

XF602

NOMESCO Finland

Bloodpressure monitoring

4.1

103.3

367

464

B05DA

ATC

Isotonic solutions

5.7

103.2

256

229

J01CF05

ATC

flucloxacillin; systemic

1.8

103.1

1880

5471

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.0

103.0

1385

3642

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.1

103.0

1118

2709

Z2221

NOMESCO Finland

Medical doctor

1.3

103.0

8947

36224

JN4BD

NOMESCO Finland

Extensive body CT

1.6

102.9

2969

9785

N06AA10

ATC

nortriptyline; systemic

2.9

102.7

609

1099

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.1

102.7

523

860

-, ,

ICD-10 Finland

2.9

102.5

603

1083

SPAT1236

SPAT

Informing family of child’s disability

2.9

102.5

597

1066

I49.1

ICD-10 Finland

Atrial premature depolarization

2.2

102.5

999

2314

P18

ICPC

Medication abuse

6.0

102.4

246

212

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

102.4

4223

15057

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

102.3

2355

7326

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

102.1

572

998

SPAT1285

SPAT

Provision of consultation response

1.9

102.0

1473

3972

Y96.8

ICD-10 Finland

Other type of accident

5.3

102.0

275

269

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

102.0

1166

2884

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.7

102.0

413

579

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

101.9

526

872

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

101.9

1692

4780

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.0

101.7

1247

3170

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

101.4

1334

3481

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.1

101.3

1135

2785

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.0

101.3

553

950

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.5

101.2

440

650

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

101.1

3958

13959

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.8

101.1

1724

4912

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

100.9

837

1802

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

100.8

7122

27939

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

100.8

1112

2712

L09

ICPC

Arm symptom/complaint

2.0

100.6

1374

3633

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.3

100.5

335

401

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

100.4

635

1189

-57

ICPC

Physical medicine/rehabilitation

10.1

100.4

167

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

100.1

843

1828

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

100.1

2305

7171

DFF59

NOMESCO Finland

Other assessment of balance

4.9

100.0

286

297

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

99.9

1489

4059

K05.30

ICD-10 Finland

Periodontitis complex

1.5

99.9

4173

14912

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

99.7

1756

5054

137

Kela drug reimbursment

Uraemia requiring dialysis

4.8

99.6

295

317

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

99.3

2940

9746

R01AD01

ATC

beclometasone; nasal

1.4

99.2

4603

16788

A10AA02, ,

ATC

2.3

99.1

948

2178

R49.08

ICD-10 Finland

Other specified dysphonia

2.8

99.0

594

1079

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

99.0

1281

3322

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

98.8

758

1571

N05AB03

ATC

perphenazine; systemic, rectal

2.2

98.8

1044

2502

F43.00

ICD-10 Finland

Acute stress reaction mild

2.5

98.8

727

1476

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.1

98.3

1076

2616

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

98.3

4035

14367

G54.0

ICD-10 Finland

Brachial plexus disorders

2.5

98.1

742

1527

M54

ICD-10 Finland

Dorsalgia

1.5

98.1

4073

14535

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

98.0

6286

24267

N05AH02

ATC

clozapine; systemic

2.8

98.0

621

1164

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

97.7

533

915

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

97.7

530

907

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

97.6

1040

2501

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

97.6

3123

10541

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

97.5

831

1812

NG2AA

NOMESCO Finland

Patella X-ray examination

2.5

97.4

747

1548

RF120, ,

NOMESCO Finland

4.4

97.1

318

375

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

97.0

3613

12605

F40.1

ICD-10 Finland

Social phobias

2.4

96.8

821

1786

SPAT1043

SPAT

Audiometry

1.6

96.6

2543

8189

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

96.5

969

2273

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

96.1

2374

7523

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.5

96.0

715

1460

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

96.0

580

1058

R78

ICPC

Acute bronchitis/bronchiolitis

2.7

96.0

610

1145

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

95.9

571

1033

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

95.9

962

2256

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.7

95.9

289

316

L84

ICD-10 Finland

Corns and callosities

2.2

95.8

940

2183

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.2

95.7

945

2201

A10BJ06

ATC

semaglutide; parenteral

1.9

95.6

1338

3568

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

95.6

1928

5778

A27

ICPC

Fear of other disease NOS

1.9

95.6

1352

3619

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.1

95.5

1092

2701

ZX112

NOMESCO Finland

Subcutaneous

2.8

95.5

591

1093

C10AA04

ATC

fluvastatin; oral

1.7

95.5

2236

6985

D07XC01

ATC

betamethasone; topical

1.5

95.4

3641

12767

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

95.4

1611

4576

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.8

95.3

367

495

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.9

95.2

353

462

SPAT1283

SPAT

Restricted health certificate

1.4

95.2

5999

23084

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

95.1

633

1219

F45.0

ICD-10 Finland

Somatization disorder

8.1

95.1

181

115

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

95.0

1462

4028

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

95.0

801

1738

TGC00

NOMESCO Finland

Bronchial lavation

2.5

95.0

696

1410

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

95.0

633

1220

J01FA15

ATC

telithromycin; oral

1.6

94.9

2947

9875

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.0

94.9

340

433

S22

ICPC

Nail symptom/complaint

1.8

94.8

1813

5349

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

94.8

1695

4901

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.8

94.5

569

1036

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.2

94.4

942

2204

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

94.2

2094

6450

R19.5

ICD-10 Finland

Other faecal abnormalities

3.3

94.2

441

686

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

94.1

1324

3538

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.2

94.1

471

766

D07AA02

ATC

hydrocortisone; topical

1.4

94.0

4586

16872

R15

ICD-10 Finland

Faecal incontinence

2.7

93.8

634

1231

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.9

93.8

551

989

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

93.8

1537

4323

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

93.7

3432

11927

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.7

93.7

624

1202

S20.2

ICD-10 Finland

Contusion of thorax

1.8

93.7

1601

4564

L99

ICPC

Musculoskeletal disease other

2.7

93.2

606

1152

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

93.2

3255

11198

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

93.2

1097

2745

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

93.1

1755

5156

Z31.5

ICD-10 Finland

Genetic counselling

1.8

93.0

1582

4503

C08DA01

ATC

verapamil; systemic

2.0

92.8

1172

3011

V03AE01

ATC

polystyrene sulfonate; oral

3.6

92.8

392

567

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.5

92.7

294

337

K03.00

ICD-10 Finland

Approximal wear

1.7

92.5

2094

6482

ZX100

NOMESCO Finland

Oral

3.5

92.4

398

584

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

13.4

91.9

133

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

91.6

3698

13112

F03

ICPC

Eye discharge

1.7

91.6

1901

5744

SPAT1059

SPAT

Spirometry at the office

1.9

91.5

1309

3518

Z03

ICPC

Housing/neighbourhood problem

5.7

91.5

229

207

XQ801

NOMESCO Finland

Intracutantest

16.8

91.5

121

G04CB01

ATC

finasteride; oral

1.5

91.1

3193

10989

A13

ICPC

Concern/fear medical treatment

3.0

91.1

494

845

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

91.0

1379

3780

R5599

NOMESCO Finland

Other rehabilitation service

2.6

91.0

655

1315

G43.8

ICD-10 Finland

Other migraine

3.1

90.9

476

797

N18

ICPC

Paralysis/weakness

2.9

90.7

538

971

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.0

90.5

483

818

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

90.2

1064

2664

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

90.0

2022

6245

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

90.0

1014

2494

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

89.9

4819

18024

R06AX26

ATC

fexofenadine; oral

1.7

89.9

2044

6333

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.9

89.9

143

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

89.8

1642

4779

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

89.8

1207

3173

L20

ICPC

Joint symptom/complaint NOS

2.1

89.6

1039

2584

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

89.5

1120

2868

L60.0

ICD-10 Finland

Ingrowing nail

1.9

89.3

1360

3734

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

89.1

586

1121

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.8

89.1

349

477

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

89.1

2880

9735

S82

ICPC

Naevus/mole

1.4

89.1

4049

14691

R07.2

ICD-10 Finland

Precordial pain

2.7

88.8

595

1150

A07EC02

ATC

mesalazine; oral, rectal

1.8

88.8

1637

4776

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

88.7

2271

7259

I49.5

ICD-10 Finland

Sick sinus syndrome

2.1

88.7

993

2436

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.4

88.6

754

1643

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

3.3

88.6

417

651

H60.3

ICD-10 Finland

Other infective otitis externa

2.5

88.4

665

1365

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

2.1

88.3

965

2344

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.1

88.3

244

245

E87.6

ICD-10 Finland

Hypokalaemia

2.2

88.3

923

2202

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

88.1

2424

7889

C02AC05

ATC

moxonidine; oral

2.0

88.0

1204

3185

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.4

88.0

736

1591

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

87.9

827

1886

Angiography of the heart and coronary arteries

1.8

87.9

1645

4821

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

87.8

4413

16313

R25.2

ICD-10 Finland

Cramp and spasm

2.4

87.7

711

1514

183

Kela drug reimbursment

Lamotrigin and topiramate

4.3

87.7

290

345

H26.4

ICD-10 Finland

After-cataract

1.6

87.6

2395

7782

NG1EA, ,

SPAT

9.2

87.5

153

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

87.3

677

1411

K28

ICPC

Limited function/disability (K)

2.7

87.2

582

1123

D01AE16

ATC

amorolfine; topical

1.5

87.1

3332

11679

E000006, ,

ATC

1.7

87.1

1870

5703

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

87.0

1764

5292

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

87.0

732

1587

K99

ICPC

Cardiovascular disease other

2.4

86.9

716

1537

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

86.8

1621

4747

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

86.7

2121

6700

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

86.7

2737

9201

K05

ICPC

Irregular heartbeat other

2.3

86.6

814

1856

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

86.5

1083

2774

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.0

86.3

317

412

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

86.3

2510

8277

R75

ICPC

Sinusitis acute/chronic

1.9

86.2

1327

3656

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.7

86.2

573

1103

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

86.2

761

1687

B05DB

ATC

Hypertonic solutions

5.4

86.2

226

215

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.4

86.1

381

570

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

86.1

1422

4009

L81

ICPC

Injury musculoskeletal NOS

2.5

86.0

645

1322

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.8

85.8

533

988

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

85.7

947

2311

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

85.7

619

1245

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

85.7

1350

3748

M89.0

ICD-10 Finland

Algoneurodystrophy

4.7

85.7

258

282

K85

ICPC

Elevated blood pressure

1.4

85.4

4319

15978

G50.1

ICD-10 Finland

Atypical facial pain

3.0

85.4

460

784

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

85.2

217

200

R30.1

ICD-10 Finland

Vesical tenesmus

2.6

85.2

601

1194

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.0

85.0

452

764

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

84.9

870

2058

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

84.9

1172

3110

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.6

84.9

214

195

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

84.9

535

1000

J01MA06

ATC

norfloxacin; oral

1.5

84.8

3767

13600

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

84.7

805

1844

S12

ICPC

Insect bite/sting

1.6

84.7

2242

7225

M77.4

ICD-10 Finland

Metatarsalgia

1.7

84.7

1701

5090

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

84.6

822

1901

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.8

84.6

328

445

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

84.6

1134

2978

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.0

84.6

463

797

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

84.5

2000

6262

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

84.5

1062

2724

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

84.4

777

1755

-60

ICPC

Result test/procedure

1.8

84.4

1524

4418

P02

ICPC

Acute stress reaction

1.8

84.2

1569

4591

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.2

83.8

287

352

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

83.8

591

1174

GD1AA, ,

SPAT

1.4

83.7

3958

14460

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

83.5

678

1445

N03AX14

ATC

levetiracetam; systemic

2.2

83.4

813

1883

L18

ICPC

Muscle pain

1.9

83.3

1199

3229

XG460

NOMESCO Finland

Short time oxymetry

3.0

83.2

453

777

J01FA01

ATC

erythromycin; systemic

1.4

83.0

4577

17189

M03BX01

ATC

baclofen; systemic

2.8

83.0

521

972

N99

ICPC

Neurological disease other

3.6

82.6

340

483

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

82.4

424

702

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

82.4

668

1423

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

82.4

1765

5378

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.9

82.2

1310

3650

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

82.2

2063

6558

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.7

82.2

330

460

E86

ICD-10 Finland

Volume depletion

2.4

82.0

697

1518

XQ899

NOMESCO Finland

Other assessment of skin

10.5

81.8

133

N05AL01

ATC

sulpiride; systemic

3.1

81.7

425

709

N80

ICPC

Head injury other

2.7

81.6

543

1046

TKC50

NOMESCO Finland

Training of urinary bladder

24.6

81.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

81.4

1145

3059

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

81.3

2060

6564

-48

ICPC

Clarification/discussion RFE/demand

2.2

81.1

819

1926

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

81.1

662

1415

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.7

80.9

329

463

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

80.9

846

2019

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

80.6

921

2277

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.8

80.6

235

249

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.1

80.6

287

364

C09AA02

ATC

enalapril; systemic

1.4

80.5

5690

22243

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

80.4

654

1395

L01BA01

ATC

methotrexate; systemic

2.0

80.4

989

2516

L10

ICPC

Elbow symptom/complaint

1.8

80.4

1550

4582

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

80.2

2005

6366

A10BJ02

ATC

liraglutide; parenteral

2.3

80.1

751

1710

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.1

80.1

889

2173

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

80.0

3421

12254

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

80.0

1663

5024

G35

ICD-10 Finland

Multiple sclerosis

2.9

80.0

472

850

C07AG02

ATC

carvedilol; oral

1.7

80.0

1575

4685

UDC00

NOMESCO Finland

Ear microscopy

1.7

79.9

1910

5994

I50.0

ICD-10 Finland

Congestive heart failure

1.6

79.8

2060

6594

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.7

79.8

530

1020

A92

ICPC

Allergy/allergic reaction NOS

2.2

79.7

847

2034

J01DC02

ATC

cefuroxime; systemic

1.7

79.5

1623

4877

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.0

79.3

421

711

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.0

79.3

443

772

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

79.3

2382

7912

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.0

79.2

425

723

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

79.2

809

1912

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.6

79.1

327

466

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

79.1

462

827

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

79.1

579

1173

R4190

NOMESCO Finland

Nutritional therapy

2.0

78.9

1024

2657

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.2

78.9

379

600

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

78.9

4450

16767

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.6

78.9

323

457

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.1

78.8

410

684

L04AA01

ATC

[U] ciclosporin

3.2

78.7

382

609

P16

ICPC

Acute alcohol abuse

2.7

78.6

530

1028

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

78.6

858

2084

N05BA02

ATC

chlordiazepoxide; systemic

2.4

78.5

659

1427

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

78.5

669

1459

H16.0

ICD-10 Finland

Corneal ulcer

1.8

78.4

1423

4131

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.6

78.2

541

1064

H60.8

ICD-10 Finland

Other otitis externa

2.1

78.0

843

2039

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.7

77.9

1718

5276

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

77.8

2322

7699

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

77.8

2918

10178

K04.09

ICD-10 Finland

Pulpit UNS

1.8

77.8

1360

3903

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.1

77.7

894

2217

SBB10

NOMESCO Finland

Dental impressions

1.6

77.6

2100

6802

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

77.5

1134

3071

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

6.9

77.4

165

123

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.9

77.3

437

767

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

4.3

77.3

255

303

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000850) Epithelial cells [#/volume] in Urine

9199

30894

1.65

323.31

3.0

2.3

5.17

6.03

e6/l

6.68

8504

27155

(3000494) Fungus identified in Specimen by Culture

5475

15845

1.87

319.69

1.6

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4733

13038

1.95

319.38

2.8

2.3

34.92

43.57

u/l

2.39

4034

11231

(3017143) Hepatitis C virus Ab [Presence] in Serum

6222

18770

1.80

318.87

1.8

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2489

5242

2.51

317.87

1.8

1.6

1.51

1.52

g/l

0.23

2135

4415

(3033658) Prothrombin time (PT) actual/Normal

11160

39531

1.59

315.71

4.7

3.4

90.49

90.20

0.52

10845

38586

(3004588) Protein electrophoresis panel - Serum or Plasma

3270

7840

2.22

315.30

2.3

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2441

5113

2.52

315.08

2.1

1.9

39.71

39.15

u/l

0.57

2187

4542

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1070

1307

4.26

313.67

1.8

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38128

173956

1.70

307.65

5.0

4.1

2.72

2.84

mmol/l

115.61

35266

161516

(3001604) Monocytes [#/volume] in Blood

23522

73822

2.29

307.65

7.0

5.0

0.58

0.59

e9/l

0.94

21173

62223

(3026361) Erythrocytes [#/volume] in Blood

42951

202005

2.31

307.65

26.5

15.1

4.50

4.56

e12/l

99.94

42121

194431

(3018418) pH of Serum or Plasma

12090

42753

1.60

307.65

4.9

3.6

7.39

7.40

7.77

1638

9825

(3022948) Iron [Moles/volume] in Serum or Plasma

8089

20506

2.23

307.65

2.9

2.1

13.37

13.52

umol/l

0.77

7538

18995

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

40453

172681

2.63

307.65

18.2

10.5

21.95

24.89

mg/l

52.59

33427

130950

(3035941) MCH [Entitic mass]

42943

201949

2.30

307.65

26.4

15.1

30.27

30.22

5.16

42410

198558

(3009542) Hematocrit [Volume Fraction] of Blood

42912

201504

2.31

307.65

26.6

15.3

40.19

40.95

11.91

41130

188392

(3023103) Potassium [Moles/volume] in Serum or Plasma

40710

173425

2.73

307.65

20.0

12.1

3.97

3.96

mmol/l

7.12

39684

167539

(3020779) Urea [Moles/volume] in Serum or Plasma

4578

11114

2.23

307.65

9.9

5.8

9.76

9.63

mmol/l

0.48

4338

10540

(3019550) Sodium [Moles/volume] in Serum or Plasma

40663

172706

2.75

307.65

19.8

12.0

139.60

139.67

mmol/l

6.84

39730

167234

(3000963) Hemoglobin [Mass/volume] in Blood

42961

202102

2.31

307.65

26.7

15.2

135.32

137.08

g/l

102.37

42420

198772

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

15075

38820

2.47

307.65

2.4

1.9

216.30

227.76

u/l

0.39

14256

36186

(40760892) CBC W Ordered Manual Differential panel - Blood

22135

69997

2.19

307.65

7.4

5.7

—

(3019069) Monocytes/100 leukocytes in Blood

22257

70615

2.18

307.65

7.6

5.4

8.52

8.54

0.61

20892

66028

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6654

16527

2.24

307.65

7.4

4.7

1.06

1.03

mmol/l

7.35

6181

15357

(3028707) Methadone [Presence] in Urine by Screen method

1507

2066

3.82

307.65

4.2

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

4031

9961

2.17

307.65

4.3

2.7

4.67

4.56

kpa

2.24

3895

9637

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28810

115876

1.73

307.65

3.9

2.5

50.24

44.96

u/l

16.29

27002

108981

(3022621) pH of Urine by Test strip

3792

9130

2.22

307.65

3.1

2.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

10713

29612

2.11

307.65

1.6

1.4

20.03

19.90

nmol/l

0.35

9161

25503

(3001122) Ferritin [Mass/volume] in Serum or Plasma

19885

68621

1.85

307.65

3.4

2.5

128.67

121.54

ug/l

2.01

18457

63723

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7554

22871

1.82

307.65

3.2

2.6

2.38

2.81

e6/l

2.20

4944

10583

(3023368) Bacteria identified in Blood by Culture

12530

37892

1.95

307.65

4.6

4.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5538

11186

2.74

307.65

2.4

2.2

365.63

382.37

nmol/l

6.52

5010

10404

(3024522) Salmonella sp identified in Specimen by Organism specific culture

987

1069

4.80

307.65

1.5

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9013

22870

2.26

307.65

1.8

1.7

1100.22

1208.25

nmol/l

19.41

6693

17102

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

41464

187334

2.33

307.65

12.5

8.0

27.50

27.03

u/l

2.17

40092

180212

(3022096) Basophils/100 leukocytes in Blood

21497

67852

2.16

307.65

7.2

5.2

0.68

0.66

4.50

20095

63152

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37705

170870

1.71

307.65

4.7

3.7

4.57

4.74

mmol/l

165.25

34995

159823

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6767

20770

1.78

307.65

2.0

1.6

1.49

1.37

26.27

6006

18455

(3037121) Protein [Mass/volume] in Urine

2066

3799

2.86

307.65

3.2

3.4

0.38

0.31

g/l

1.34

854

1909

(3026008) Bacteria identified in Urine by Culture

12757

42090

1.76

307.65

3.3

2.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23707

74195

2.31

307.65

6.8

5.5

11.08

11.97

umol/l

16.89

22489

69995

(36304419) Bacteria [Presence] in Urine

11709

41238

1.61

307.65

3.6

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

13279

45799

1.68

307.65

3.8

2.7

68.45

110.71

e6/l

2.52

10991

33126

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7517

22662

1.83

307.65

1.3

1.2

11.80

11.57

u/ml

0.09

2816

9261

(3000330) Specific gravity of Urine by Test strip

3377

6091

2.98

307.65

3.7

3.0

—

(3002032) Base excess in Venous blood by calculation

4892

12064

2.20

307.65

5.1

3.3

2.02

1.78

mmol/l

3.88

4126

10294

(3018010) Neutrophils/100 leukocytes in Blood

22478

72295

2.15

307.65

7.1

5.0

57.15

0.01

21170

67781

(3009343) pH of Capillary blood

4201

6954

3.30

307.65

4.1

3.0

7.42

0.46

274

1441

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

35586

151547

1.88

307.65

6.4

4.6

39.83

38.73

mmol/mol

73.37

32910

140456

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5260

14416

1.98

307.65

1.9

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7398

20772

1.98

307.65

2.5

1.9

29.92

29.95

0.13

7210

20175

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

977

1049

4.84

307.65

1.5

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8316

24348

1.91

307.65

3.0

2.5

1.05

1.34

e6/l

1.19

5689

12009

(3007164) IgA [Mass/volume] in Serum or Plasma

9842

27734

2.04

307.65

1.6

1.4

2.34

2.39

g/l

1.42

6062

17573

(3030467) Casts [#/volume] in Urine by Automated count

12346

41744

1.70

307.65

3.7

2.7

0.35

0.47

e6/l

5.58

10184

29740

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1001

1100

4.73

307.65

1.5

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4777

9097

2.88

307.65

2.5

2.0

6.90

8.55

ug/l

4.16

3992

7947

(3005322) IgE [Units/volume] in Serum or Plasma

3392

7961

2.27

307.65

1.4

1.2

261.07

257.48

u/ml

0.03

3156

7349

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7718

21912

1.96

307.65

4.0

3.1

0.82

mmol/l

2.27

7190

20503

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8300

20486

2.31

307.65

2.0

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17702

52149

2.20

307.65

4.2

3.0

94.27

61.91

ng/l

0.53

12121

32546

(3013512) EKG study

13794

38371

2.20

307.65

4.5

3.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

37416

162981

1.93

307.65

4.9

3.8

5.96

5.81

mmol/l

78.25

34282

149068

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

37971

159745

2.23

307.65

15.1

10.4

84.17

84.63

ml/min/173m2

3.24

33242

127339

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19059

57744

2.17

307.65

2.5

2.0

4873.22

75.52

nmol/l

0.50

17092

52234

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3665

8034

2.45

307.65

1.3

1.2

47.40

52.40

au/ml

0.54

162

478

(3048689) Calprotectin [Mass/mass] in Stool

6697

16859

2.21

307.65

2.4

2.5

125.17

140.14

ug/g

2.37

5305

13469

(40768797) Stomach Pathology biopsy report

6749

16374

2.30

307.65

1.3

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

15449

42705

2.28

307.65

3.0

2.3

60.26

65.56

u/l

0.59

14348

39261

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4760

12258

2.10

307.65

2.7

2.0

0.22

g/l

0.05

4394

11373

(40761535) Cells panel - Urine sediment

4786

9159

2.87

307.65

3.7

2.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3715

8708

2.29

307.65

1.8

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

854

804

5.52

307.65

3.1

2.9

57.34

57.86

0.20

691

686

(3014111) Lactate [Moles/volume] in Serum or Plasma

4666

11649

2.17

307.65

6.9

7.1

1.38

1.36

mmol/l

0.50

4552

11347

(3018095) Leukocytes [#/volume] in Urine

15341

54091

1.68

307.65

4.2

3.1

79.43

99.68

e6/l

2.12

11705

35755

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14971

50448

1.77

307.65

3.7

2.7

34.64

34.16

u/l

0.14

14246

47612

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

36655

162667

1.75

307.65

4.3

3.4

1.33

1.28

mmol/l

28.65

33748

150375

(3012516) Albumin [Mass/volume] in Urine

12060

39414

1.77

307.65

3.8

3.0

348.12

331.08

mg/l

0.15

7657

24986

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

37324

153187

2.30

307.65

5.4

3.9

2.08

2.18

mu/l

0.30

34443

140304

(3013826) Glucose [Moles/volume] in Serum or Plasma

26458

87180

2.30

307.65

5.5

4.1

6.71

6.63

mmol/l

5.53

24958

80035

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3904

8210

2.56

307.65

4.7

3.4

92.12

87.83

ng/l

1.58

3411

7042

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6634

14366

2.59

307.65

7.4

5.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3629

6638

2.95

307.65

1.8

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5875

14476

2.23

307.65

4.8

3.9

235.86

246.47

u/l

4.91

5501

13743

(3022217) INR in Platelet poor plasma by Coagulation assay

21436

64610

2.30

307.65

15.1

12.6

1.26

1.23

inr

1.52

5547

20553

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9193

25556

2.05

307.65

4.1

3.1

367.25

603.38

ng/l

5.67

6813

19281

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41362

185851

2.36

307.65

19.8

12.2

79.17

76.20

umol/l

44.08

41340

185750

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7979

24309

1.82

307.65

1.3

1.2

43.20

37.20

iu/ml

0.39

2365

8006

(3044640) Blood type and Crossmatch panel - Blood

14425

47989

1.78

307.65

2.8

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

18849

61088

1.98

307.65

5.4

4.3

35.81

35.61

g/l

4.29

17519

56379

(40758558) Short blood count panel - Blood

12548

36085

2.07

307.65

8.1

6.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

22730

73820

2.13

307.65

7.3

5.2

28.01

28.19

1.43

21389

69291

(3022313) Gas panel - Capillary blood

3334

4615

3.90

307.65

4.2

3.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

20312

73399

1.74

307.65

2.9

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4237

7013

3.30

307.65

4.1

3.0

5.15

5.14

kpa

0.04

3974

6660

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4845

12123

2.17

307.65

5.1

3.3

5.86

5.81

kpa

2.55

4709

11786

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19123

53844

2.40

307.65

2.1

1.7

97.35

94.96

pmol/l

7.90

10460

27786

(3012544) pH of Venous blood

4960

12574

2.14

307.65

5.1

3.3

7.37

7.38

0.26

120

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

20396

61883

2.23

307.65

7.0

5.3

1.21

mmol/l

7.88

18485

56482

(3020682) Albumin/Creatinine [Ratio] in Urine

12597

41669

1.75

307.65

4.4

3.5

11.03

8.60

mg/mmol

4.53

8016

26151

(3026493) Urate [Moles/volume] in Serum or Plasma

11531

39503

1.66

307.65

3.0

2.3

3722.13

5217.21

umol/l

3.47

10129

34906

(3014576) Chloride [Moles/volume] in Serum or Plasma

5798

16941

1.86

307.65

7.7

7.0

104.54

104.47

mmol/l

0.49

5793

16928

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7455

13987

3.06

307.65

4.8

3.8

32.07

31.71

1.53

5156

9667

(3013115) Eosinophils [#/volume] in Blood

24334

76579

2.33

307.65

7.4

5.2

0.19

e9/l

0.11

21848

65951

(3014051) Protein [Presence] in Urine by Test strip

2191

2582

4.51

307.65

2.7

2.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13684

34263

2.48

307.65

3.4

2.7

1416.78

1467.62

ng/l

0.51

11468

28949

(40761511) CBC panel - Blood by Automated count

40974

184588

2.23

307.65

16.4

10.0

—

(3023520) Reticulocytes [#/volume] in Blood

4353

9808

2.40

307.65

2.7

2.5

71.28

68.47

e9/l

4.31

3502

6942

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

986

1052

4.88

307.65

1.5

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4720

10070

2.56

307.65

3.3

2.2

66.09

69.24

ml/min/173m2

3.61

1619

4014

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11038

32090

2.00

307.65

1.3

1.2

1.76

1.75

u/ml

0.03

2712

9244

(3028026) IgM [Mass/volume] in Serum or Plasma

3236

7376

2.34

307.65

1.9

1.30

1.29

g/l

0.06

2932

6729

(3006315) Basophils [#/volume] in Blood

23605

73950

2.30

307.65

7.0

5.0

0.04

e9/l

4.97

21219

62268

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11801

34788

1.99

307.65

2.7

2.0

—

(3010813) Leukocytes [#/volume] in Blood

42968

202012

2.32

307.65

26.6

15.1

6.85

6.69

e9/l

30.59

42137

194402

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7457

18911

2.21

307.65

2.9

2.1

2.34

2.33

g/l

0.60

6929

17289

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3964

8825

2.42

307.65

2.5

2.3

23.12

22.59

au/ml

0.11

310

832

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

22846

67077

2.47

307.65

8.1

5.4

1.21

mmol/l

0.70

20265

54168

(3024731) MCV [Entitic volume]

42951

201971

2.31

307.65

26.4

15.1

90.82

90.50

39.03

42413

198576

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6992

17627

2.21

307.65

3.0

2.2

22.91

23.42

1.86

6195

15050

(3015377) Calcium [Moles/volume] in Serum or Plasma

14277

47837

1.76

307.65

3.2

3.5

2.35

mmol/l

2.55

12137

42828

(3011397) Hemoglobin [Presence] in Urine by Test strip

10184

34036

1.68

307.65

4.1

2.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

978

1049

4.85

307.65

1.5

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5193

14572

1.93

307.65

1.9

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

32094

124314

2.06

307.65

4.4

3.4

14.74

14.66

pmol/l

5.70

29425

112410

(3005988) Vibrio sp identified in Specimen by Organism specific culture

978

1051

4.84

307.65

1.5

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3145

3925

4.32

307.65

4.3

3.2

24.63

24.82

mmol/l

2.30

2902

3640

(40768804) Tissue Pathology biopsy report

17007

61950

1.64

307.65

2.2

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

27997

102701

2.01

307.65

5.2

3.6

1232.99

1221.25

e6/l

0.01

191

2104

(3013650) Neutrophils [#/volume] in Blood by Automated count

26378

87436

2.27

307.65

10.2

8.0

4.11

4.16

e9/l

3.01

23812

74326

(3005719) IgG [Mass/volume] in Serum or Plasma

4216

9367

2.43

307.65

2.9

2.4

10.46

10.79

g/l

4.48

3895

8450

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5717

15734

1.98

307.65

3.4

2.4

7.96

9.27

umol/l

3.56

5007

13497

(3019225) pH of Specimen

6527

9927

3.75

307.65

4.9

3.4

—

(3009508) Creatinine [Moles/volume] in Urine

13582

43362

1.85

307.65

3.9

2.9

7.80

8.10

mmol/l

7.69

11212

36770

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2329

4018

3.07

307.65

2.4

2.2

434.68

629.37

ug/l

1.35

2152

3776

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2682

3915

3.66

307.65

2.0

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3970

9716

2.19

307.65

2.5

2.3

66.71

66.51

g/l

0.80

3570

8895

(3006504) Eosinophils/100 leukocytes in Blood

22176

70113

2.19

307.65

7.2

5.2

2.87

2.82

2.71

20782

65481

(3013707) Erythrocyte sedimentation rate by Westergren method

31685

114112

2.35

307.65

4.8

3.2

11.57

11.24

mm/h

3.55

29376

105150

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37405

169579

1.68

307.65

4.7

3.7

1.41

1.45

mmol/l

51.89

34608

157772

(3045414) Leukocytes [Presence] in Urine

3152

4870

3.48

307.65

2.1

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4048

6779

3.25

307.65

4.0

3.0

1.32

1.94

mmol/l

16.72

2997

4909

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2926

4251

3.69

307.65

2.2

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3512

6902

2.73

307.65

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

11037

30772

2.10

307.65

2.1

1.6

1.11

1.25

mg/l

3.16

8171

23494

(3027945) Reticulocytes/100 erythrocytes in Blood

5513

14261

2.11

307.65

2.8

2.4

1.81

1.70

9.24

4786

12640

(4146454) Self-monitoring of blood glucose

1219

540

11.83

307.65

3.1

1.9

—

(3042936) Bacteria identified in Isolate by Culture

6811

19259

1.95

307.65

2.3

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

29418

109502

2.04

307.65

5.1

3.4

—

(3017732) Neutrophils [#/volume] in Blood

3991

9273

2.31

307.65

2.9

2.5

4.73

4.84

e9/l

0.20

3015

7880

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12339

33342

2.22

307.65

2.5

2.0

2.96

2.89

mg/l

2.16

10466

28180

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

32845

117793

2.49

307.65

8.8

6.4

78.05

78.04

u/l

0.02

31183

110138

(3019198) Lymphocytes [#/volume] in Blood

24096

77118

2.25

307.65

7.1

5.0

1.91

1.94

e9/l

1.82

21923

67012

(3007853) Bacteria identified in Skin by Aerobe culture

5926

15749

2.06

307.65

2.0

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

7198

18526

2.17

307.65

1.4

1.3

526.30

532.21

titre

0.08

1512

3333

(3007461) Platelets [#/volume] in Blood

42931

201686

2.31

307.65

26.6

15.2

251.25

251.83

e9/l

0.99

42189

194805

(3022145) Colonoscopy Study observation

5260

15209

1.87

307.11

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2441

5295

2.43

292.94

1.5

11.14

13.17

u/ml

0.29

137

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2503

5504

2.40

291.90

4.7

3.4

50.11

48.06

3.24

2473

5447

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1676

2988

2.94

289.82

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1390

2202

3.30

289.48

1.5

1.2

—

(4200892) Spirometry reversibility

3539

9074

2.08

288.38

1.5

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1690

3040

2.91

287.87

1.5

1.4

284.94

267.99

ug/g

1.61

954

1750

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2020

4045

2.62

283.96

1.5

1.6

243.75

296.48

titre

0.31

172

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1750

3262

2.81

280.29

1.4

11.49

13.48

iu/ml

0.21

(36660697) Celiac disease serology panel - Serum

4051

11127

1.94

273.29

1.2

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

19594

79949

1.44

272.03

4.2

3.0

0.01

0.00

estimate

1.35

3267

16960

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1350

2241

3.14

261.64

1.3

1.2

17.08

16.19

u/ml

0.03

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4935

14668

1.81

261.46

7.5

7.3

5.10

5.08

kpa

0.68

4714

13931

(3027801) Oxygen [Partial pressure] in Arterial blood

4932

14657

1.81

261.41

7.5

7.2

12.26

12.63

kpa

4.34

4701

13915

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1816

3618

2.63

257.35

1.9

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1697

3262

2.72

256.98

1.3

1.2

34.00

36.99

u/ml

0.15

101

213

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

27822

121886

1.42

253.24

3.4

3.0

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2147

4726

2.39

248.97

2.0

1.8

1.61

2.54

ug/l

3.13

1864

4212

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3264

8577

2.02

247.86

3.4

3.5

4.49

4.55

pmol/l

1.98

2864

7746

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1569

2945

2.79

247.85

1.4

1.3

490.68

566.75

mg/l

1.80

1503

2818

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3692

10167

1.93

246.03

3.1

2.6

214.21

212.01

ng/l

0.09

3364

9192

(3003396) Base excess in Arterial blood by calculation

4899

14823

1.77

243.67

7.5

7.2

1.00

0.90

mmol/l

1.01

3829

11880

(3044889) 12 lead EKG panel

26008

112981

1.41

243.20

3.9

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

19574

81005

1.41

240.83

4.2

3.0

0.00

estimate

0.69

2992

15837

(3004616) Nuclear Ab [Presence] in Serum

883

1148

3.99

239.96

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1567

3017

2.71

236.35

1.3

1.2

5.06

9.88

u/ml

2.27

247

418

(3021601) Nitrite [Presence] in Urine by Test strip

19361

80146

1.41

236.21

5.7

4.0

0.00

estimate

5.11

3054

16313

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1927

4130

2.45

236.08

2.2

2.1

7.38

7.41

g/l

0.30

1712

3744

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6060

19656

1.66

234.82

2.3

1.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

743

849

4.53

234.62

1.9

2.2

20.74

18.85

nmol/l

3.92

672

817

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1920

4127

2.44

233.77

2.2

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4388

12994

1.80

233.67

2.6

2.0

12.07

12.76

nmol/l

5.74

3862

11874

(3009214) Lutropin [Units/volume] in Serum or Plasma

2114

4759

2.33

233.24

1.6

1.3

8.76

8.89

u/l

0.16

1717

3872

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1546

2976

2.71

233.23

1.3

1.2

4.53

10.95

u/ml

1.19

149

274

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1917

4123

2.44

233.11

2.2

2.1

3.65

3.85

g/l

5.97

1709

3738

(3016502) Oxygen saturation in Arterial blood

4383

12995

1.80

232.41

8.0

7.7

95.37

95.64

1.67

4243

12462

(3021589) Normoblasts [#/volume] in Blood

17735

72567

1.41

228.84

10.1

8.7

0.00

e9/l

0.01

15086

57745

(46235355) HIV 1 and 2 tests - Meaningful Use set

9555

34730

1.51

228.65

2.1

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2543

6257

2.14

228.11

2.5

2.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1306

2318

2.94

226.95

1.3

1.2

4.23

7.31

u/ml

0.55

177

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2600

6474

2.12

226.38

5.5

3.5

24.14

24.12

mmol/l

0.16

2531

6335

(3011288) Drugs identified in Urine by Screen method

1991

4426

2.36

225.63

4.6

2.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1082

1735

3.24

220.86

1.4

1.3

23.33

25.65

u/l

1.17

846

1477

(3000991) Gas panel - Venous blood

4018

11784

1.81

220.01

9.4

7.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1774

3785

2.45

219.10

1.9

1.5

1.18

g/l

0.59

1705

3627

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1380

2581

2.79

219.10

1.4

1.2

3.77

3.70

mmol/l

1.32

1310

2431

(3027273) Bicarbonate [Moles/volume] in Venous blood

2462

6081

2.13

218.52

4.5

2.9

25.16

25.25

mmol/l

0.59

2399

5881

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2720

7012

2.05

216.36

8.9

9.8

24.29

24.34

mmol/l

0.36

2612

6776

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1724

3662

2.46

214.82

1.9

1.5

0.23

0.24

g/l

1.76

1655

3496

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1590

3255

2.55

213.30

2.2

2.0

11.65

10.26

mg/l

6.22

1473

3081

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1809

3955

2.39

212.23

2.2

2.1

10.14

10.37

g/l

1.11

1591

3550

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1789

3914

2.39

209.53

2.3

2.1

2.91

3.03

g/l

4.01

1578

3530

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

752

971

4.01

206.01

1.8

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1000

1599

3.25

204.91

2.1

1.7

3.56

3.29

titre

0.06

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1311

2475

2.76

204.59

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1947

4484

2.27

203.68

1.8

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6495

22160

1.58

202.98

2.4

1.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

934

1440

3.36

201.96

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

794

1091

3.77

201.09

3.8

3.4

—

(3015736) pH of Urine

15899

64927

1.39

199.03

3.9

2.7

5.86

0.08

1166

5911

(3013139) Helicobacter pylori Ag [Presence] in Stool

3156

8834

1.89

198.75

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2093

5047

2.17

196.53

1.3

1.2

0.89

0.64

u/ml

0.49

207

498

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

693

879

4.08

194.00

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

974

1587

3.18

193.92

1.8

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

974

1588

3.18

193.73

1.8

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8429

30839

1.49

190.42

1.6

1.7

19287375.16

35141064.44

pmol/l

2.06

6984

25526

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7937

28680

1.50

190.41

1.8

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7264

25795

1.52

188.91

2.8

3.2

2.44

2.45

mmol/l

11.28

6365

22337

(3004809) Band form neutrophils/100 leukocytes in Blood

1049

1831

2.97

187.18

3.4

2.8

1.39

1.56

0.71

906

1635

(3017181) Myelocytes/100 leukocytes in Blood

3777

11403

1.76

186.44

4.7

3.6

0.90

0.99

1.01

1507

3586

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1260

2471

2.65

183.24

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1277

2530

2.63

182.18

3.3

2.4

33.19

35.13

umol/l

1.32

1161

2272

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1191

2274

2.72

181.96

1.2

98.18

93.33

titre

0.05

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

843

1309

3.34

180.34

1.8

1.5

1864.76

5351.11

titre

0.72

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

817

1244

3.40

179.81

2.3

1.7

24.82

29.15

mg/l

0.94

177

390

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13382

53808

1.38

178.91

4.9

4.4

2.76

3.10

ug/l

1.03

11942

48375

(3024980) IgG subclass 4 [Mass/volume] in Serum

1048

1882

2.89

178.28

1.7

1.5

0.84

0.85

g/l

0.04

828

1294

(3009466) Valproate [Moles/volume] in Serum or Plasma

991

1723

2.98

177.94

5.5

4.5

372.08

363.35

umol/l

0.88

849

1468

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4302

13648

1.67

177.59

3.5

4.3

18.78

33.11

ug/l

1.94

3429

10888

(3038026) Centromere Ab [Units/volume] in Serum

587

699

4.34

176.96

1.3

1.2

38.19

51.20

u/ml

0.35

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1326

2734

2.52

175.04

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

3607

10936

1.74

174.97

4.7

3.6

0.09

0.13

2.93

1351

3131

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1243

2487

2.60

173.98

7.1

3.7

783.61

3917.93

iu/ml

0.65

203

261

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

556

644

4.46

172.93

3.2

2.2

666.22

650.88

e6/l

0.24

538

615

(3007566) Smooth muscle Ab [Titer] in Serum

1601

3636

2.30

172.41

1.3

1.2

99.71

133.99

titre

0.87

139

368

(3004119) Hemoglobin [Mass/volume] in Venous blood

2836

8022

1.86

172.17

4.2

2.9

129.91

130.92

g/l

1.34

2782

7832

(3019150) Specific gravity of Urine by Refractometry

8682

32515

1.45

171.86

4.6

3.2

1.02

kg/l

0.59

1478

4853

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3961

12405

1.69

171.13

1.5

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

571

684

4.31

170.97

1.3

1.2

82.97

61.77

u/ml

0.63

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

572

687

4.30

170.76

1.3

1.2

29.87

46.34

u/ml

0.81

(3026250) Tacrolimus [Mass/volume] in Blood

403

345

6.02

168.50

39.1

31.7

7.44

7.48

ug/l

0.08

365

317

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

591

746

4.09

166.41

1.8

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

591

746

4.09

166.41

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

591

746

4.09

166.41

1.8

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

1562

3565

2.28

166.28

1.3

1.2

638.68

1180.51

titre

2.21

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

518

584

4.58

165.97

3.3

2.2

0.23

e9/l

0.22

443

484

(3005570) Glucose [Moles/volume] in Urine

675

951

3.67

165.38

2.0

1.7

72.54

8.12

mmol/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

550

658

4.31

164.93

1.3

1.2

7.94

6.84

u/ml

0.11

(1001926) Buprenorphine [Presence] in Urine by Screen method

2146

5597

2.01

164.36

3.4

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

528

613

4.44

163.80

3.2

2.1

516.72

508.93

e6/l

0.09

442

484

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2427

6623

1.92

163.73

2.7

2.1

5427.16

6753.41

u/l

1.18

940

2704

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

391

337

5.97

162.55

2.6

2.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3444

10520

1.73

162.26

4.5

3.5

0.68

0.03

1342

3022

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2008

5182

2.03

158.10

2.0

1.6

38.95

40.07

nmol/l

1.15

1910

5106

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1481

3379

2.28

157.68

2.1

37.92

37.62

g/l

0.90

1265

2990

(3014271) Vancomycin [Susceptibility]

426

418

5.25

157.36

3.1

2.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1925

4898

2.05

157.32

1.6

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1273

2712

2.44

157.14

1.5

1.3

17.16

23.15

u/ml

0.71

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1273

2717

2.44

156.54

1.6

1.4

4031.48

968.67

e6/l

0.57

1083

2124

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1230

2586

2.47

156.00

1.4

1.2

273.40

251.98

u/ml

1.46

779

1677

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1715

4194

2.13

154.99

1.6

19.20

2.28

iu/ml

0.72

304

883

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1268

2715

2.43

154.88

1.5

1.4

14.72

32.09

e6/l

1.72

1034

1993

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2705

7811

1.82

153.42

1.1

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1955

5052

2.02

153.29

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

901

1618

2.88

153.20

1.3

0.18

0.25

nmol/l

0.86

107

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1554

3680

2.20

151.76

2.3

2.4

0.82

0.85

g/l

0.07

1346

3151

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1268

2748

2.40

150.98

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

641

934

3.54

150.06

3.4

2.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2272

6246

1.90

149.68

3.5

2.5

1.32

1.29

0.65

2258

6213

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

393

377

5.37

148.35

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

393

378

5.35

147.98

1.5

1.3

—

(3026782) Osmolality of Urine

8044

30438

1.43

147.61

3.4

2.5

540.08

555.52

mosm/kgh2o

7.01

7043

25853

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

891

1627

2.84

147.20

1.3

0.58

2.35

nmol/l

1.12

872

1557

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2222

6137

1.89

144.27

3.5

2.5

0.67

0.65

2.48

2210

6114

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

799

1387

2.98

143.76

1.3

—

nmol/l

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

950

1825

2.70

143.36

3.7

2.1

875.44

4103.11

u/ml

1.90

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1590

3896

2.13

142.84

2.8

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

2629

7709

1.79

141.56

3.2

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1465

3487

2.19

141.24

2.1

1.8

194.22

201.42

pmol/l

1.47

1398

3332

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

741

1242

3.08

141.07

1.1

3.06

7.64

au/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3416

10803

1.67

141.07

1.3

1.2

132.33

149.91

iu/ml

1.50

1138

4283

(3036180) Methadone [Presence] in Urine

454

528

4.43

140.61

2.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

2644

7803

1.78

139.31

3.2

1.6

—

(3027008) Opiates [Presence] in Urine

2636

7779

1.78

138.90

3.2

1.6

—

(3036489) Thrombin time

2001

5405

1.93

138.52

2.6

1.8

21.27

21.34

0.16

1744

4693

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3786

12356

1.62

138.25

8.8

7.9

122.25

122.68

g/l

0.55

3710

11979

(3016879) Cocaine [Presence] in Urine

2457

7131

1.80

136.66

3.3

1.7

—

(3044927) Protein electrophoresis panel - Urine

594

877

3.50

136.55

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

2844

8633

1.73

136.06

1.3

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

719

1212

3.07

135.65

1.1

70.61

63.22

au/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1491

3642

2.13

134.90

3.4

3.1

37.21

43.83

mg/l

0.93

1329

2625

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

401

433

4.77

134.59

2.1

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

401

433

4.77

134.59

2.1

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1456

3530

2.15

134.18

3.3

3.1

3.46

4.63

ratio

0.17

109

203

(3034860) Kappa light chains.free [Mass/volume] in Serum

1490

3655

2.12

133.39

3.4

3.1

52.38

63.95

mg/l

0.58

1335

2638

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1482

3628

2.12

133.34

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1181

2632

2.33

132.29

1.3

1.2

39.67

47.38

u/ml

0.63

266

(3011412) CD3 cells [#/volume] in Blood

644

1028

3.23

132.21

3.0

2.0

1.27

1.11

e9/l

3.33

563

919

(3021387) Prolactin [Units/volume] in Serum or Plasma

2210

6279

1.84

131.39

1.7

1.6

334.19

292.57

mu/l

4.08

2010

5575

(3025159) Blasts/100 leukocytes in Blood

3293

10523

1.65

130.27

4.7

3.7

0.27

0.26

0.01

1034

2761

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

803

1485

2.80

129.73

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2398

7017

1.79

129.70

3.0

2.4

0.30

0.29

e6/l

0.12

2351

6799

(3002385) Erythrocyte distribution width [Ratio]

32954

154783

1.31

129.39

19.8

12.9

15.32

14.78

6.04

32576

151034

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

597

919

3.35

129.33

1.2

1.1

37.07

44.78

mg/l

3.34

536

734

(3044290) Cell count panel - Cerebral spinal fluid

1186

2678

2.30

129.04

1.5

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1559

3954

2.05

128.11

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

452

571

4.08

127.21

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1365

3305

2.15

126.13

2.2

0.03

0.02

g/l

0.58

1256

3017

(3024666) Lithium [Moles/volume] in Serum or Plasma

471

621

3.91

125.77

12.8

11.6

0.62

mmol/l

0.19

432

562

(3010375) cycloSPORINE [Mass/volume] in Blood

370

395

4.82

125.70

29.2

23.8

111.73

127.25

ug/l

1.93

305

344

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

573

875

3.38

125.59

1.1

250.52

261.39

mg/l

0.48

533

751

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1139

2565

2.30

124.64

1.6

1.3

106.23

104.53

u/ml

0.23

193

614

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

759

1394

2.81

124.11

7.1

5.4

11.22

mg/l

0.01

699

1269

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

441

564

4.03

122.29

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

974

2057

2.45

122.26

1.9

4.95

5.39

mmol/24h

3.00

847

1864

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

604

974

3.20

122.12

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1298

3125

2.16

121.58

2.2

0.00

g/l

0.06

1193

2845

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2740

8499

1.69

120.89

9.8

9.1

1.42

1.34

3.09

2716

8448

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2737

8502

1.69

120.09

9.9

9.2

0.67

0.66

0.29

2714

8457

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

431

551

4.03

119.58

1.1

4.10

9.31

nmol/l

1.00

134

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1005

2178

2.39

119.52

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1622

4296

1.96

118.44

3.3

2.3

3.48

3.70

g/l

6.05

1561

4096

(3014765) Yersinia sp identified in Stool by Organism specific culture

1494

3843

2.02

118.17

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1276

3089

2.14

117.90

2.3

2.2

0.00

g/l

-0.00

1190

2837

(42529406) Shigella sp [Presence] in Stool by Culture

1494

3849

2.02

117.67

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

491

710

3.56

116.21

3.4

3.1

25.10

27.96

mu/l

0.73

443

680

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1480

3821

2.01

115.89

1.2

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2729

8555

1.67

115.62

10.0

9.3

94.01

93.78

1.07

2717

8524

(3027944) Amphetamines [Presence] in Urine

2523

7755

1.70

114.88

2.9

1.6

—

(4062490) Immunoglobulin typing, IgG

663

1179

2.90

114.60

1.6

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1612

4315

1.94

114.19

3.7

2.9

0.35

u/ml

0.33

951

2338

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1565

4148

1.96

113.99

3.2

2.2

178.49

187.79

3.54

1494

3936

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

551

876

3.24

113.84

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

660

1179

2.89

113.21

1.5

1.3

2.85

3.04

g/l

1.41

499

692

(3027135) IgG subclass 1 [Mass/volume] in Serum

660

1181

2.88

112.89

1.5

1.3

6.85

7.02

g/l

0.37

499

691

(3049717) Cytology report of Urine Cyto stain

1744

4815

1.89

112.86

2.5

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

659

1179

2.89

112.75

1.5

1.3

0.38

0.42

g/l

1.67

504

688

(3020191) Ethanol [Moles/volume] in Serum or Plasma

604

1026

3.04

112.59

1.6

1.4

1.52

1.37

promille

1.25

462

762

(3020961) Endomysium IgA Ab [Titer] in Serum

2348

7148

1.72

110.54

1.2

1.1

175.02

250.91

titre

0.72

214

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

431

587

3.78

110.48

1.4

1.3

—

(3019060) Gas panel - Arterial blood

2618

8216

1.67

110.31

4.8

4.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

455

649

3.61

109.73

2.8

3.7

134.78

130.56

nmol/l

0.07

449

640

(21494815) CD4 cells/100 lymphocytes in Specimen

582

984

3.05

109.32

2.5

2.0

39.77

38.09

1.49

564

970

(3008037) Lactate [Moles/volume] in Venous blood

1162

2798

2.15

108.73

3.9

2.7

1.52

1.64

mmol/l

3.58

1139

2740

(3019420) Tryptase [Mass/volume] in Serum or Plasma

370

451

4.22

108.70

1.6

7.69

7.25

ug/l

0.20

344

398

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

750

1477

2.62

108.04

2.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

703

1337

2.71

108.03

1.3

1.2

29.70

21.57

nmol/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

270

244

5.69

107.80

3.7

2.8

—

(1761868) Lipid panel - Serum or Plasma

11808

72489

0.78

106.89

2.7

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

1131

2717

2.16

106.42

3.6

3.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1675

4652

1.87

106.40

2.8

2.0

93.04

91.87

1.19

1618

4453

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

673

1262

2.75

106.10

3.1

3.3

6.82

9.52

nmol/l

0.26

658

1230

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

712

1380

2.66

105.68

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

309

332

4.78

104.35

2.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

309

332

4.78

104.35

2.3

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1118

2701

2.14

103.75

2.8

1.5

0.85

0.82

nmol/l

0.63

865

2378

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

310

339

4.70

102.78

2.2

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

618

1127

2.83

102.34

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1911

5619

1.77

101.20

1.1

15.35

4.08

u/ml

0.64

(3027923) C peptide [Moles/volume] in Serum or Plasma

390

528

3.80

100.79

1.7

1.6

1.26

1.24

nmol/l

0.11

257

440

(3038515) Glucose [Moles/volume] in Venous blood

1105

2702

2.12

99.51

4.0

2.7

7.33

7.73

mmol/l

3.94

1084

2651

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1703

4867

1.82

98.91

4.9

4.5

1.67

1.68

0.12

1625

4510

(3042733) HLA Ab [Presence] in Serum

287

305

4.84

98.06

4.9

5.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1246

3216

2.01

97.51

3.2

2.9

24.43

24.82

mmol/l

2.56

1218

3146

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1170

2975

2.04

95.28

1.8

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

353

464

3.91

94.73

1.1

7.48

8.15

u/ml

0.11

(3028626) Oxygen [Partial pressure] in Capillary blood

1258

3302

1.97

94.00

3.6

2.9

8.48

8.31

kpa

2.35

1223

3227

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

956

2257

2.19

93.77

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

884

2021

2.26

93.44

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1167

2988

2.02

93.30

1.6

1.5

14023.74

13810.00

e6/l

0.05

899

2108

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

515

891

2.98

93.24

1.3

1.2

1.97

2.11

mmol/l

1.37

480

829

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

783

1701

2.38

92.63

1.1

1.48

1.51

g/l

0.83

695

1554

(3045424) Erythrocytes [Presence] in Urine

869

1982

2.27

92.36

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

583

1098

2.74

91.23

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1414

3905

1.88

91.22

4.8

2.8

1.49

1.46

mg/l

0.52

1292

3604

(3048879) Bone marrow aspiration report

227

204

5.71

91.16

2.0

1.6

—

(3024932) HLA-DR beta [Type]

279

312

4.59

90.37

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

840

1913

2.27

89.58

1.3

41.67

28.05

u/l

1.76

726

1643

(3020876) Protein [Mass/time] in 24 hour Urine

623

1233

2.61

88.94

2.3

2.7

1.30

g/24h

0.02

287

672

(3037756) Immunofixation for Serum or Plasma

956

2309

2.14

88.74

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

852

1962

2.24

88.58

1.5

1.4

62.72

62.89

mmol/l

0.03

654

1525

(3007930) Methemoglobin/Hemoglobin.total in Blood

1640

4802

1.77

87.90

5.0

4.5

0.83

0.90

10.35

1568

4446

(3018405) Lactate [Moles/volume] in Arterial blood

1526

4374

1.81

87.68

4.4

4.0

1.40

1.44

mmol/l

0.58

1493

4306

(3024471) HLA-A [Type]

280

323

4.45

87.68

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

401

618

3.34

86.85

1.4

6.51

5.97

u/l

0.39

342

525

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

496

876

2.92

86.81

1.1

281.49

286.19

mg/l

0.62

439

795

(40761536) Microorganisms panel - Urine sediment

2335

18105

0.64

86.48

4.5

3.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

315

415

3.90

84.35

2.2

1.5

1.95

1.97

umol/l

0.13

289

387

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

454

775

3.02

84.06

1.3

1.2

—

(40768443) Skin Pathology biopsy report

1962

6121

1.67

84.01

1.2

—

(3003338) MCHC [Mass/volume]

33076

158214

1.25

83.93

22.4

12.9

332.68

333.20

g/l

19.68

32832

156691

(3023511) Choriogonadotropin [Units/volume] in Urine

1175

3137

1.94

83.66

1.4

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

450

768

3.02

83.35

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

900

2181

2.13

82.86

1.3

1.2

3.48

3.94

u/ml

0.71

389

997

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8199

33655

1.30

82.82

1.7

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

482

863

2.88

82.46

2.4

1.9

72.59

72.42

0.07

459

834

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

387

605

3.29

82.11

1.0

305.36

334.64

ng/l

0.81

236

474

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

581

1158

2.59

81.86

1.7

1.4

—

(21494755) Public health laboratory ask at order entry panel

3368

24065

0.69

81.64

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

581

1160

2.58

81.59

1.7

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

355

528

3.46

80.94

3.0

2.4

39.24

38.49

0.22

175

265

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

474

851

2.87

80.72

2.4

1.8

13.94

15.49

2.15

457

832

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

386

610

3.25

80.60

1.0

41.38

41.83

ng/l

0.06

230

470

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1411

4051

1.81

80.60

1.1

7.61

4.83

u/ml

0.58

142

691

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

175

134

6.70

80.38

1.4

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

1331

3760

1.83

80.03

4.7

4.2

3.86

3.91

mmol/l

2.82

1314

3731

(3032057) Clostridioides difficile [Presence] in Stool

191

164

5.98

79.88

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

786

1831

2.22

79.58

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

384

611

3.23

79.37

1.0

762.61

712.06

ng/l

0.97

228

455

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

488

904

2.78

78.71

21.5

16.2

3351.45

3071.98

nmol/l

0.04

477

871

(3039162) Centromere protein B Ab [Units/volume] in Serum

698

1555

2.32

78.22

1.3

1.2

58.73

49.27

u/ml

0.31

104

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

327

471

3.57

77.97

2.9

1.6

144.13

109.98

umol/l

0.90

162

225

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

471

860

2.82

77.93

14.8

11.2

821.76

1998.29

nmol/l

0.51

463

826

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

140

8.75

77.55

5.8

6.7

62.50

71.63

1.56

(3014148) Varicella zoster virus Ab [Titer] in Serum

815

1951

2.16

77.33

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1511

4487

1.75

77.13

1.9

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

714

1618

2.28

77.03

2.6

2.1

105.71

105.50

mmol/l

0.48

709

1601

(3041354) Potassium [Moles/volume] in Venous blood

714

1618

2.28

77.03

2.6

2.1

4.04

4.07

mmol/l

1.03

709

1602

(3023419) Bacteria identified in Sputum by Culture

723

1663

2.24

75.40

2.9

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

931

2372

2.03

75.39

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

509

992

2.64

74.88

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

5055

19613

1.36

74.64

1.8

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

508

991

2.64

74.60

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

508

992

2.64

74.46

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

419

737

2.92

73.91

1.6

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

307

442

3.57

73.27

1.1

667.43

406.23

ng/l

0.29

115

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1228

3484

1.82

72.81

1.8

1.9

4.29

9.97

iu/l

0.49

440

1340

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2743

9579

1.49

72.53

2.0

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

500

982

2.62

72.51

1.2

—

(3010503) CD19 cells [#/volume] in Blood

398

687

2.98

72.44

3.2

2.2

0.26

0.21

e9/l

0.19

383

671

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

500

983

2.62

72.37

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

500

984

2.62

72.23

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1077

2940

1.89

71.86

1.9

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

696

1614

2.22

71.25

2.6

2.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

686

1581

2.24

71.24

1.1

2.36

2.01

iu/ml

0.16

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

270

361

3.84

71.05

1.4

14.75

15.05

pmol/l

0.22

218

311

(3008898) HLA-B27 [Presence]

1712

5383

1.65

71.00

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

369

616

3.08

70.89

2.0

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

927

2413

1.98

70.85

1.1

2470.97

815.22

iu/ml

0.54

224

514

(3020891) Body temperature

1695

5322

1.65

70.67

5.4

4.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

902

2327

2.00

70.64

1.2

3.48

3.90

u/ml

0.21

311

820

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

243

303

4.12

69.69

2.2

1.3

1059.17

2159.61

u/ml

0.81

(3047007) Chlamydophila sp Ab [Presence] in Serum

819

2049

2.06

69.58

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

812

2026

2.07

69.47

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1241

3585

1.79

69.43

5.0

3.3

—

(3011985) Renin [Units/volume] in Plasma

734

1764

2.15

69.01

1.6

1.5

69.80

67.88

mu/l

0.05

644

1576

(21494434) Karyotype in Bone marrow

453

867

2.69

68.96

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

349

573

3.13

68.83

1.7

1.5

1970875.66

1242353.00

iu/ml

0.63

(3026389) Candida sp identified in Specimen by Organism specific culture

718

1715

2.16

68.52

1.5

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

395

707

2.87

67.70

3.0

1.7

95.45

97.91

0.60

381

659

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

434

822

2.72

67.35

1.6

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

179

175

5.25

66.62

2.1

2.0

16.49

17.09

umol/l

0.22

179

175

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

288

429

3.45

65.63

1.9

2.6

0.94

1.20

ug/l

1.13

267

401

(3020717) Zinc [Moles/volume] in Serum or Plasma

317

507

3.21

65.12

1.8

1.3

23.39

29.60

umol/l

2.27

297

477

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3372

12509

1.41

64.74

2.1

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1691

5426

1.62

64.71

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

866

2274

1.97

64.62

1.1

—

(3008295) Osmolality of Serum or Plasma

563

1242

2.33

64.53

1.6

1.4

282.38

279.40

mosm/kgh2o

1.74

418

977

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

33.05

64.42

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1644

5248

1.62

64.21

1.3

215.25

230.27

miu/ml

0.85

715

2544

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

257

359

3.68

63.96

2.8

1.7

30.18

28.84

0.58

240

340

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

865

2283

1.96

63.63

1.9

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

367

653

2.89

63.58

1.1

1.05

1.11

u/l

0.55

164

309

(3006245) CD3-CD19+ cells/100 cells in Blood

262

373

3.61

63.57

2.8

1.8

11.12

10.85

0.09

243

351

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

391

726

2.77

62.91

1.4

1.2

5.20

5.53

umol/l

0.76

359

683

(3028433) Virus identified in Specimen by Culture

239

320

3.83

62.85

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2729

9789

1.45

62.83

8.2

6.3

24.93

24.71

mmol/l

2.41

2717

9685

(3000492) Spirometry study

4294

16664

1.35

62.58

1.5

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

149

5.51

62.36

5.4

4.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1064

3032

1.81

62.20

1.1

5.44

5.80

u/ml

0.27

651

1474

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

226

292

3.97

62.15

2.3

1.5

37.84

34.53

u/l

0.10

207

260

(3002256) Pathology report gross observation

5230

20926

1.31

61.82

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

286

443

3.32

61.65

2.2

1.4

27.52

29.32

umol/l

1.92

275

423

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

277

420

3.39

61.59

3.3

2.3

—

(3045142) Bone marrow Pathology biopsy report

574

1305

2.26

61.55

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1202

3567

1.74

61.44

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

538

1190

2.33

61.34

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1221

3644

1.73

61.19

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

425

839

2.60

61.12

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

135

106

6.53

60.90

3.0

3.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2259

7881

1.49

59.73

7.7

6.5

24.45

mmol/l

0.00

2163

7436

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

819

2173

1.94

59.37

1.1

117.40

117.66

0.07

753

1952

(3045683) HLA typing for celiac disease panel - Blood or Tissue

414

822

2.59

58.90

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2379

8424

1.47

58.41

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

411

821

2.57

57.81

2.5

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

669

1667

2.07

57.49

1.4

392.60

303.43

pmol/l

1.26

569

1457

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

512

1144

2.30

57.12

3.8

3.7

—

(3000060) B lymphocytes [#/volume] in Blood

210

275

3.92

56.84

2.9

1.7

486.77

1558.89

e6/l

0.55

124

135

(3020911) Cortisol [Moles/time] in 24 hour Urine

263

408

3.31

56.61

1.5

1.3

173.49

307.43

nmol/24h

0.60

263

408

(3052851) Hemolysis interference index of Serum or Plasma

1379

4346

1.64

56.59

3.4

2.9

—

(3003694) ABO and Rh group [Type] in Blood

11656

51620

1.21

56.40

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

612

1488

2.12

55.98

2.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

313

547

2.94

55.95

2.0

1.7

144.75

142.37

0.17

297

516

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9880

43118

1.22

55.33

3.9

21.80

21.89

0.19

4645

19691

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

372

724

2.64

55.01

1.6

1.5

21.49

25.66

u/ml

0.83

149

(4035726) Immunohistochemistry procedure

3493

13379

1.36

55.00

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

327

595

2.82

54.60

1.3

1.2

64.55

103.78

titre

0.47

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

827

2269

1.88

54.39

1.1

13.95

11.63

au/ml

0.25

187

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

289

490

3.03

54.30

1.4

452.61

886.23

mu/l

1.14

271

470

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

294

504

3.00

54.26

1.4

72.43

72.67

0.09

276

484

(3016018) Differential panel - Cerebral spinal fluid

603

1481

2.10

53.80

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

548

1295

2.18

53.76

1.2

65.47

68.80

u/l

0.28

501

1145

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

133

5.40

53.64

1.1

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14089

63740

1.19

53.23

4.5

3.0

—

(3024928) Oxygen saturation in Venous blood

952

2757

1.78

52.84

4.1

2.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2270

8120

1.45

52.81

1.5

1.3

22.92

27.35

iu/l

8.47

1954

6874

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

333

625

2.74

52.66

1.3

1.2

396.67

515.45

titre

0.18

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1004

2958

1.75

52.61

1.1

0.77

1.22

u/ml

2.00

515

1166

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

339

643

2.71

52.60

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1429

4633

1.60

52.36

1.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

340

650

2.69

52.00

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

412

878

2.41

50.96

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1060

3207

1.71

50.64

2.1

2.2

133.85

117.22

ug/min

0.39

612

1921

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

300

544

2.83

50.43

1.9

1.5

11.91

5.02

nmol/l

0.40

244

455

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

294

527

2.86

50.42

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

306

562

2.80

50.32

2.2

2.0

39.17

51.49

umol/l

0.33

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1457

4792

1.57

50.27

3.0

3.6

867.19

2917.96

u/ml

0.86

1260

4129

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

10.78

50.04

3.6

2.3

2.13

2.47

mg/l

0.42

(3006922) Hepatitis E virus Ab [Presence] in Serum

437

968

2.32

49.77

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

132

128

5.29

49.64

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

196

271

3.71

49.57

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

278

487

2.93

49.57

4.2

13.8

—

(3023410) Appearance of Cerebral spinal fluid

548

1343

2.10

49.20

1.9

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1114

3451

1.67

48.81

1.1

1.51

2.38

u/ml

2.53

652

1618

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

583

1469

2.04

48.74

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

406

878

2.38

48.71

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

407

882

2.37

48.62

1.1

—

(3001556) Androgen free Index in Serum or Plasma

126

119

5.43

48.58

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

197

278

3.63

48.51

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

161

194

4.25

48.23

1.3

133.68

65.35

mu/l

0.72

112

151

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

196

279

3.60

47.71

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

279

3.60

47.71

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

776

2185

1.83

47.18

3.0

0.81

nmol/l

0.03

529

1730

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

613

1598

1.97

46.78

1.2

1.1

96.07

96.76

0.23

574

1500

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

187

262

3.66

46.51

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

660

2.57

46.43

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

266

473

2.89

46.29

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7343

31581

1.22

46.28

2.9

2.8

0.73

0.79

ug/l

2.95

4873

19300

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

143

161

4.55

46.24

1.0

—

(40768446) Kidney Pathology biopsy report

270

487

2.85

45.87

1.8

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

125

5.12

45.67

1.7

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

699

1932

1.86

45.03

1.7

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

224

367

3.13

44.54

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

340

708

2.47

44.19

1.3

1.2

93.49

86.06

u/l

0.48

296

615

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

12.07

43.68

4.8

4.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

104

5.92

43.41

2.1

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

268

497

2.77

43.41

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

271

506

2.75

43.36

2.5

2.3

159.59

148.36

nmol/l

0.59

245

408

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

150

187

4.11

43.24

1.6

1.4

0.42

0.46

ug/l

0.34

124

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

380

844

2.31

43.10

1.8

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

208

332

3.21

43.06

1.5

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

171

240

3.65

42.48

1.3

1.2

368.94

332.68

pmol/l

0.13

114

183

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

448

1079

2.13

42.09

1.2

163.51

197.87

titre

0.36

169

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

447

1076

2.14

42.05

1.2

185.00

153.64

titre

0.10

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

270

512

2.71

42.03

1.1

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

408

946

2.22

41.99

2.0

1.7

3.64

3.86

mg/l

0.40

385

890

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

412

961

2.20

41.82

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

326

688

2.43

41.26

1.3

1.2

21.63

24.15

u/l

0.45

282

590

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

6.35

41.19

2.2

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

886

2702

1.69

41.18

1.6

1.4

0.35

0.43

nmol/l

1.15

698

2150

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

132

154

4.39

41.10

1.3

1.2

—

(3034426) Prothrombin time (PT)

240

432

2.85

40.98

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

215

363

3.04

40.82

1.3

1.2

0.30

0.31

g/l

0.47

187

281

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.69

40.44

2.7

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

479

1205

2.04

40.31

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

159

221

3.69

40.04

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

391

913

2.20

39.62

1.4

1.2

1.81

2.26

u/ml

0.37

268

406

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

759

2241

1.74

39.56

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1008

3217

1.62

39.40

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1008

3219

1.61

39.30

1.4

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

290

593

2.51

39.16

1.2

170.85

167.00

mmol/24h

0.24

290

593

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

234

427

2.81

39.05

2.1

1.7

174.81

160.65

0.82

226

394

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

198

327

3.11

38.96

1.3

1.2

111.17

110.53

0.10

183

290

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

702

2035

1.78

38.94

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

236

435

2.78

38.70

1.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

130

158

4.22

38.66

1.7

1.3

686.55

101.26

ng/l

0.48

105

(40768441) Liver Pathology biopsy report

397

949

2.15

38.05

1.7

1.2

—

(3017704) Immunofixation for Urine

259

508

2.62

37.94

1.7

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

458

1160

2.03

37.90

2.2

1.9

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

107

111

4.94

37.78

1.2

1.3

48.24

54.25

0.38

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

157

226

3.56

37.76

1.3

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

229

421

2.79

37.74

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

590

1641

1.85

37.37

2.1

1.8

19.57

27.21

ug/l

3.95

572

1620

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

166

251

3.39

37.29

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

777

2353

1.70

37.08

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

931

2961

1.62

36.91

1.1

1.42

2.20

u/ml

2.47

569

1335

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

148

208

3.65

36.78

1.5

—

(3006270) Folate [Moles/volume] in Blood

439

1110

2.03

36.51

1.2

1.1

345.89

394.28

nmol/l

4.26

361

938

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

227

425

2.74

36.25

1.4

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

1152

3871

1.54

36.21

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

121

147

4.22

36.04

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

847

2646

1.65

36.03

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

627

1799

1.79

36.01

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

850

2668

1.64

35.51

2.6

4.0

593.85

1073.63

u/ml

0.72

758

2445

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

400

988

2.08

35.37

1.4

1.3

12.49

11.99

umol/l

0.66

374

944

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

160

245

3.35

35.32

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

160

245

3.35

35.32

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

160

245

3.35

35.32

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

160

245

3.35

35.32

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

138

191

3.70

35.02

1.1

0.71

0.96

umol/24h

0.36

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

377

918

2.11

34.58

1.1

1.2

1.06

1.07

ratio

0.69

106

424

(3016038) Potassium [Moles/volume] in Urine

328

754

2.23

34.55

1.4

1.2

33.56

35.53

mmol/l

0.72

267

660

(3034274) Bile acid [Moles/volume] in Serum --fasting

757

2323

1.68

34.46

2.3

2.2

8.57

6.24

umol/l

1.03

533

1702

(3036670) Protein [Mass/volume] in Synovial fluid

181

307

3.02

34.21

1.2

40.20

40.83

g/l

0.19

101

167

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1939

7301

1.37

33.57

11.4

9.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

588

1693

1.79

33.43

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

110

133

4.24

32.99

1.2

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

136

195

3.57

32.96

1.5

1.3

0.23

0.25

nmol/l

0.13

100

130

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

161

260

3.17

32.88

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

332

785

2.17

32.76

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

291

654

2.28

32.31

1.1

1488.26

1452.99

miu/ml

0.19

291

654

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

196

361

2.78

32.29

1.0

13.63

11.44

u/ml

0.42

239

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

110

137

4.11

31.88

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

517

1458

1.82

31.45

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

442

1194

1.90

30.67

1.4

1.3

152636.53

95127.13

e6/l

0.86

311

819

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

453

1235

1.88

30.59

4.6

5.1

88.42

92.73

u/ml

0.06

121

448

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

258

564

2.35

30.48

2.2

2.3

54.06

50.86

umol/l

0.79

223

472

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

108

139

3.98

30.12

1.4

1.5

6.92

499167.84

nmol/l

1.73

119

(3008536) Aspergillus sp Ab [Presence] in Serum

126

183

3.53

30.05

2.6

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

110

144

3.91

30.04

1.8

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

208

412

2.59

30.03

1.1

90.68

92.15

0.22

101

185

(3021901) Oxygen saturation in Capillary blood

808

2615

1.59

29.93

2.9

2.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

208

414

2.58

29.76

1.1

1.2

108.47

106.70

0.24

197

376

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

204

402

2.60

29.75

1.1

1.2

88.62

92.50

0.57

100

184

(3007916) DNA double strand Ab [Titer] in Serum

111

4.38

29.66

1.3

1.4

160.00

59.59

titre

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

275

629

2.24

29.40

2.4

2.3

102.34

178.09

ug/l

0.25

264

598

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

113

154

3.76

29.34

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

254

562

2.32

29.26

1.7

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

254

562

2.32

29.26

1.7

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.26

29.00

1.3

1.1

27.21

16.53

0.45

(3024263) Appearance of Synovial fluid

268

612

2.25

28.77

1.4

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

126

189

3.42

28.75

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

153

262

2.99

28.57

1.5

1.2

16.55

16.66

umol/l

0.09

137

231

(3011897) Casein IgE Ab [Units/volume] in Serum

125

189

3.39

28.22

1.1

1.3

0.69

2.52

u/ml

1.10

125

184

(3022493) Free Hemoglobin [Mass/volume] in Plasma

246

548

2.30

27.94

7.5

4.0

1410.39

4697.73

mg/l

1.37

183

371

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

5.71

27.64

1.0

0.10

0.11

u/ml

0.06

(3009015) Lactate [Moles/volume] in Synovial fluid

4.99

27.60

1.3

6.25

5.67

mmol/l

0.31

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

314

2.76

27.51

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

521

1537

1.74

27.40

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

113

4.17

27.17

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

187

370

2.59

27.12

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

4.20

27.10

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

123

190

3.32

26.95

1.1

1.2

5.69

13.58

u/ml

0.78

134

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1729

6621

1.35

26.90

1.8

1.6

4.23

3.69

mg/l

1.02

1346

4509

(3016228) CD19 cells/100 cells in Blood

233

519

2.30

26.50

2.0

1.9

9.43

7.90

0.88

227

508

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

338

876

1.98

26.47

1.6

1.4

12.53

12.43

u/l

0.09

325

851

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

403

1112

1.86

26.33

1.5

1.3

1.47

1.41

nmol/l

0.47

366

1005

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

711

2310

1.58

25.98

1.1

3.25

2.81

u/ml

0.35

276

1325

(21494814) CD8 cells/100 lymphocytes in Specimen

228

508

2.30

25.93

2.0

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

520

1562

1.71

25.72

1.6

1.5

30.84

30.58

iu/ml

0.01

(3010370) Gastrin [Moles/volume] in Serum or Plasma

111

165

3.45

25.71

2.1

1.5

45.13

55.03

pmol/l

0.37

137

(40765096) Chromosome analysis panel by Banding

160

300

2.73

25.66

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

156

290

2.76

25.41

1.3

1.2

121.32

126.36

nmol/l

0.14

121

206

(3051651) Icteric interference index of Serum or Plasma

312

799

2.00

25.28

4.2

3.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

7.25

25.13

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.20

25.02

1.5

1.7

1.62

1.90

mg/l

0.15

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

566

1755

1.66

24.93

1.6

1.5

55.02

57.25

0.60

396

1097

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

148

270

2.81

24.93

1.2

71.60

78.58

0.58

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1886

7410

1.31

24.63

2.8

3.3

56.08

50.86

u/ml

0.27

1808

7178

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

5.58

24.33

1.1

22.05

15.75

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

5.58

24.33

1.1

22.45

20.94

u/ml

—

(3036603) Volume of Urine

339

907

1.92

24.32

1.5

1.6

2113.59

1938.46

2.39

325

892

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

153

289

2.71

24.25

1.2

1.3

108.27

106.84

0.16

148

270

(3012494) Peanut IgE Ab [Units/volume] in Serum

179

370

2.48

23.90

1.1

2.92

7.55

u/ml

0.92

214

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

121

3.81

23.87

1.1

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

1.05

2.19

mg/l

0.99

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

2.22

3.83

mg/l

0.80

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

2.14

2.16

mg/l

0.01

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

1.13

1.57

mg/l

0.31

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

2.08

1.11

mg/l

0.88

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

1.82

2.04

mg/l

0.08

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

0.71

0.63

mg/l

0.08

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

4.02

3.73

mg/l

0.09

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.12

23.58

1.5

1.7

2.73

3.12

mg/l

0.13

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

143

3.51

23.34

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

4.24

23.25

1.0

1.1

1.28

4.09

u/ml

1.16

(3051611) Lipemic interference index of Serum or Plasma

475

1433

1.70

23.19

3.7

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

897

3146

1.47

23.13

1.7

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

250

609

2.11

23.12

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

201

448

2.30

22.92

2.9

2.8

28.94

28.43

umol/l

0.22

139

340

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

146

278

2.69

22.84

1.3

1.2

83.24

87.49

0.32

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

164

334

2.52

22.59

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

339

933

1.86

22.42

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

103

3.98

22.42

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.38

22.27

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

4.03

22.24

1.0

1.1

0.92

12.29

u/ml

1.49

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

391

1133

1.77

21.97

2.2

2.0

1.70

2.01

u/field

0.42

171

461

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

250

624

2.05

21.77

1.2

1.1

88.60

83.19

u/l

0.35

232

546

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

331

915

1.86

21.62

1.1

6.92

9.25

iu/ml

0.81

273

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1219

4575

1.37

21.59

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

362

1032

1.80

21.47

1.1

—

(3019174) dRVVT (LA screen)

102

3.92

21.46

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

145

285

2.61

21.42

1.6

1.5

8.84

9.23

ug/l

0.41

145

285

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

197

449

2.25

21.40

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

5.12

21.40

4.9

4.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

716

5346

0.68

21.34

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

248

622

2.04

21.33

1.2

1.1

28.96

22.43

u/l

0.73

224

550

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.30

21.28

10.9

10.7

103.06

214.36

e6/l

1.16

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

274

715

1.97

21.19

1.2

4.29

20.23

u/ml

1.24

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

294

788

1.91

21.07

1.7

1.5

7.24

6.31

u/l

0.49

254

595

(3020393) Adenovirus Ag [Presence] in Stool

106

3.82

21.06

1.4

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

5.03

21.05

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

700

5235

0.68

21.05

1.4

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

125

3.52

20.65

9.4

7.0

—

(3005033) Fetal Nuchal fold Thickness US

702

5226

0.68

20.60

1.4

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

+∞

20.45

1.0

0.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

594

1961

1.56

20.40

1.6

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

3.61

20.09

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

272

723

1.93

20.00

2.0

1.7

2.23

2.40

u/field

0.15

189

573

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

112

199

2.88

19.85

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

592

1969

1.54

19.70

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

260

685

1.95

19.62

1.1

3.58

4.28

iu/ml

0.39

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

5.44

19.58

1.0

0.27

2.50

u/ml

0.48

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.89

19.37

3.4

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

193

456

2.17

19.34

1.6

1.7

—

(3018133) Calcium [Moles/volume] in Urine

155

3.14

19.32

2.1

1.7

2.84

2.62

mmol/l

0.36

140

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

4.03

19.17

1.0

1.1

0.36

7.18

u/ml

0.62

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

159

348

2.34

18.97

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.19

18.85

2.2

1.6

49.13

43.29

umol/l

0.67

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

619

2102

1.51

18.77

1.1

1.0

0.27

0.55

u/ml

1.05

233

435

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.14

18.71

3.4

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

9381

43741

1.12

18.64

4.7

3.2

0.00

estimate

0.92

2962

15461

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

292

816

1.84

18.54

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

205

506

2.08

18.46

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.49

18.44

1.1

—

(3020491) Glucose [Moles/volume] in Blood

364

1092

1.71

18.26

1.7

1.9

6.70

6.71

mmol/l

0.02

226

881

(3014133) Dog dander IgE Ab [Units/volume] in Serum

730

2582

1.45

18.14

1.1

1.0

4.94

4.47

u/ml

0.20

402

1151

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

127

3.31

18.06

1.1

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

3.15

18.04

2.2

2.0

1.15

1.56

mmol/l

0.85

112

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4.07

17.95

1.2

1.1

14.70

13.40

nmol/l

0.25

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

133

3.23

17.92

1.6

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

4.30

17.91

3.0

2.9

30.94

59.98

pmol/l

0.25

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

175

2.90

17.75

1.1

6.28

12.38

pmol/l

0.31

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

156

3.02

17.66

2.6

2.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

124

3.30

17.61

1.1

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

4.05

17.60

1.0

1.1

0.16

0.37

u/ml

0.33

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

146

319

2.34

17.53

2.6

1.9

—

(3014891) Appearance of Pleural fluid

138

3.15

17.47

1.3

—

(3007463) Buprenorphine [Presence] in Urine

5.23

17.39

5.1

12.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

252

687

1.88

17.29

1.1

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

892

3304

1.39

17.20

1.6

1.4

134.64

129.35

pmol/l

0.10

867

3239

(3044941) Cell count panel - Synovial fluid

634

2206

1.48

17.15

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

3.81

17.11

1.0

1.1

0.07

1.56

u/ml

0.81

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

520

1738

1.54

17.01

1.4

1.3

—

(4034850) Laboratory test

1008

6849

0.75

16.95

12.0

8.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

364

1116

1.67

16.93

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

975

3675

1.36

16.91

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

482

1591

1.55

16.67

1.5

1.4

2350.15

2514.21

e6/l

0.15

388

1086

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

244

668

1.87

16.56

1.0

1.1

98.26

95.99

0.53

209

515

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.90

15.99

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

181

2.74

15.90

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

634

2241

1.45

15.88

4.2

3.3

31.90

41.97

u/ml

1.13

616

2157

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1170

4578

1.31

15.84

1.9

1.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

156

2.89

15.76

1.2

1.3

32.74

48.31

mg/l

2.30

131

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

238

660

1.85

15.57

6.5

4.5

874.58

1523.52

u/ml

0.25

(3038177) Helicobacter pylori Ab [Presence] in Serum

733

2672

1.41

15.55

1.2

—

(3017569) Oxygen content in Arterial blood

192

495

1.99

15.51

2.0

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3413

20170

0.85

15.51

1.7

—

(40762814) Titanium [Mass/volume] in Blood

181

2.72

15.46

2.2

2.4

3.67

3.97

ug/l

0.14

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

274

799

1.76

15.27

6.3

7.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5779

26457

1.13

15.21

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.43

15.17

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

159

385

2.12

15.14

1.8

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

135

3.00

15.05

1.0

0.01

0.69

u/ml

1.29

(3022229) Phosphate [Moles/volume] in Urine

4.78

14.93

2.0

1.7

21.42

21.71

mmol/l

0.02

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

106

3.28

14.92

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.89

14.88

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

157

2.80

14.69

2.2

1.5

—

(3047181) Lactate [Moles/volume] in Blood

1032

4012

1.32

14.65

5.9

4.9

1.37

1.29

mmol/l

1.41

915

3445

(3047189) Immunofixation for 24 hour Urine

206

559

1.89

14.44

1.7

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

150

362

2.12

14.42

1.8

1.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

376

2942

0.65

14.38

2.6

2.2

13.13

13.11

0.21

369

2896

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.58

14.35

1.4

1.3

1.00

1.27

ml/s/173m2

1.03

(21491868) Cryoglobulin [Mass/volume] in Serum

172

439

2.01

14.33

1.2

1.1

0.87

0.23

g/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

195

2.57

14.32

1.3

1.2

80.09

186.10

titre

0.65

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

7.07

14.11

1.8

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

119

263

2.32

14.05

1.1

0.74

0.78

u/ml

0.05

249

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2251

13658

0.83

14.01

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

120

3.03

13.80

1.3

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.99

13.78

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

185

2.57

13.62

1.9

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

159

402

2.03

13.61

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

672

2472

1.40

13.60

1.1

1.0

5.53

5.77

u/ml

0.10

332

985

(40763590) HLA-DQ beta [Type]

5.85

13.43

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

437

1487

1.51

13.30

1.5

1.4

59751.71

50346.62

e6/l

0.31

311

830

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.90

13.30

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

140

341

2.10

13.21

1.3

1.2

240.85

190.40

ug/l

0.11

178

(3013862) HLA-DP [Type]

5.65

13.03

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.12

13.03

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

129

2.86

12.76

2.3

3.0

0.61

0.50

u/field

0.42

129

(3023487) Leukocytes [#/volume] in Peritoneal fluid

164

430

1.95

12.75

2.8

1.6

5042.14

2771.65

e6/l

0.21

125

265

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

7.52

12.72

1.6

1.4

425.67

180.75

nmol/l

0.82

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

205

580

1.81

12.71

3.2

2.9

7.64

8.51

mg/l

1.02

171

436

(40760409) HLA-A [Type] by High resolution

5.46

12.65

1.0

—

(40760410) HLA-B [Type] by High resolution

5.46

12.65

1.0

—

(46236302) HLA-C [Type] by High resolution typing

5.46

12.65

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

217

630

1.76

12.39

3.8

3.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.37

12.37

2.8

1.7

1.35

1.29

umol/l

0.34

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

212

612

1.77

12.33

1.2

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

187

521

1.84

12.19

2.6

2.3

161.75

147.06

au/ml

0.13

(3003434) Protein [Mass/volume] in Pleural fluid

508

1819

1.43

12.03

1.5

1.4

31.65

33.67

g/l

2.78

460

1639

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

182

505

1.85

12.02

2.2

1.8

9.30

9.64

mg/l

0.32

152

383

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.95

11.93

5.2

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

159

423

1.93

11.91

1.2

1.3

14.29

20.23

0.38

(3013247) Albumin in CSF/Albumin in Serum or Plasma

129

318

2.08

11.86

1.1

6.60

6.16

mg/g

0.26

124

305

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3154

18368

0.87

11.65

3.5

3.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

102

3.01

11.63

1.2

1.87

1.70

umol/24h

0.39

102

(3012920) Ethanol [Mass/volume] in Serum or Plasma

9.30

11.61

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

2.67

11.52

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

211

623

1.74

11.42

1.3

73.83

68.26

0.30

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

110

260

2.17

11.25

1.2

—

(3017509) Phencyclidine [Presence] in Urine

195

2.36

11.19

2.5

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

266

843

1.62

11.10

1.4

1.2

204.95

389.58

u/l

2.73

233

797

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

243

753

1.65

11.07

1.1

178.48

216.17

iu/ml

0.95

243

743

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.46

10.95

2.7

3.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.53

10.82

2.7

2.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

113

2.81

10.74

3.6

2.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

150

2.53

10.56

3.2

2.8

38.49

45.90

umol/l

1.60

130

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.46

10.53

1.1

1.4

42.88

35.56

0.39

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

2.82

10.46

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

232

2.18

10.37

1.6

1.3

20.76

21.92

0.15

190

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

351

1207

1.49

10.30

2.0

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.86

10.21

1.5

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.56

10.18

1.1

1.4

15.37

14.58

0.05

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

104

251

2.12

10.16

1.7

1.4

5.29

5.95

nmol/l

0.96

244

(3026470) Cobalt [Mass/volume] in Blood

243

771

1.61

10.15

1.9

2.0

3.94

3.53

ug/l

0.21

219

709

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

415

2977

0.71

10.12

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

146

401

1.86

10.04

1.8

1.6

96.29

140.54

au/ml

0.50

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

458

1666

1.41

10.04

1.5

1.3

156.10

199.37

pmol/l

2.01

458

1666

(3033942) Copper [Moles/time] in 24 hour Urine

3.98

10.02

1.3

1.1

1.46

0.42

umol/24h

0.69

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

402

1.86

9.97

2.5

1.5

23506.15

10548.38

e6/l

0.48

191

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

289

962

1.54

9.88

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.77

9.79

1.1

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

123

322

1.96

9.74

1.7

1.2

14.84

13.37

g/l

0.84

100

245

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

163

2.39

9.72

2.9

2.5

67.28

68.75

pmol/l

0.03

146

(40758292) HTLV I+II Ab panel - Serum

229

2.15

9.67

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

238

761

1.60

9.66

2.0

2.1

2.30

2.32

ug/l

0.03

190

659

(3002331) Protein [Mass/volume] in Peritoneal fluid

109

274

2.04

9.63

1.7

1.2

41.05

47.96

g/l

0.11

222

(40757373) Influenza virus identified in Isolate

203

2.22

9.60

1.7

1.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.14

9.58

1.0

0.20

0.93

u/ml

0.57

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.28

9.58

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

119

310

1.97

9.56

1.3

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

344

1198

1.47

9.53

1.4

1.3

390.62

510.39

u/l

1.23

332

1135

(3006184) Hemoglobin [Mass/volume] in Capillary blood

902

3661

1.27

9.41

2.1

2.2

132.01

131.42

g/l

0.27

606

2857

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.53

9.38

1.4

1.6

30.86

17.89

nmol/l

0.92

(3012441) Differential panel - Pleural fluid

410

1482

1.42

9.35

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.17

9.32

1.4

—

(3042631) Mycobacterium sp identified in Specimen

524

1978

1.36

9.25

3.1

2.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

241

2.08

9.19

1.6

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

477

1777

1.38

9.15

1.7

1.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.65

9.04

1.1

1.2

12.93

24.71

u/ml

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.24

8.96

9.8

7.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

109

282

1.98

8.96

1.2

1.1

—

(3012501) Base excess in Blood by calculation

673

4417

0.78

8.93

4.3

3.7

2.36

2.49

mmol/l

0.63

450

2964

(3013290) Carbon dioxide [Partial pressure] in Blood

673

4417

0.78

8.93

4.3

3.7

5.01

5.00

kpa

0.16

662

4318

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.70

8.93

1.0

1.1

14.64

23.36

u/ml

0.32

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

284

1.96

8.80

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

106

274

1.98

8.74

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

121

2.54

8.73

1.3

1.5

178.21

174.26

mmol/l

0.07

103

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.06

8.63

2.2

2.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

2.69

8.57

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

685

2721

1.29

8.53

3.6

2.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

108

284

1.95

8.51

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

788

3188

1.27

8.49

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

4.01

8.42

1.2

1.0

306.61

221.25

pmol/l

0.39

(3027315) Oxygen [Partial pressure] in Blood

683

4427

0.79

8.22

4.4

3.7

8.88

8.65

kpa

2.44

672

4328

(3036071) Salmonella sp Ab [Titer] in Serum

164

499

1.68

8.14

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

577

2255

1.31

8.13

1.5

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.55

8.02

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.32

7.96

1.1

1.3

1.29

0.98

0.20

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1199

7291

0.84

7.77

1.7

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

182

577

1.62

7.76

2.2

2.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

129

2.38

7.73

4.5

7.0

71.27

65.27

g/mol

0.08

124

(1002224) Polysomnography panel

1714

7567

1.16

7.60

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.13

7.52

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

5.12

7.52

1.2

2.6

2.88

1.69

mu/l

0.47

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

138

2.30

7.43

3.3

2.4

1.46

1.32

mg/l

0.10

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

157

487

1.65

7.31

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

315

1139

1.42

7.30

2.4

1.9

675.67

701.10

0.47

237

706

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.65

7.16

1.2

296.04

317.94

umol/24h

0.34

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

321

1171

1.40

7.09

1.9

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

272

965

1.44

7.00

1.3

13.47

14.33

u/l

0.22

248

910

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.69

6.87

1.0

1.1

—

(3049233) Organic acids panel - Urine

7.90

6.83

1.1

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

158

2.14

6.74

12.0

6.7

0.38

0.30

umol/l

0.84

141

(40758047) Lysozyme [Mass/volume] in Pleural fluid

122

2.31

6.68

1.1

9.21

8.93

mg/l

0.08

115

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.94

6.67

2.1

1.4

0.64

0.71

umol/l

0.30

(3018001) Oat IgE Ab [Units/volume] in Serum

2.74

6.46

1.0

0.30

u/ml

0.01

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.02

6.45

8.4

9.2

—

(3020650) Glucose [Presence] in Urine

638

0.52

6.36

1.5

1.3

—

(3033799) Differential panel - Peritoneal fluid

135

419

1.65

6.34

2.6

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.55

6.30

2.0

2.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

2.13

6.30

1.3

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.53

6.18

1.3

1.4

—

14.32

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

687

4300

0.81

6.14

4.2

3.0

26.17

27.62

mg/l

0.47

387

2834

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4235

19988

1.09

6.12

1.7

1.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.42

6.10

1.5

1.4

8.81

20.71

pmol/l

1.35

(3029612) Listeria sp Ab [Titer] in Serum

4.83

6.07

1.4

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.56

6.03

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

203

702

1.48

6.02

4.5

2.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

275

1.79

6.00

2.1

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

203

1.92

5.88

2.1

3.3

—

(3028717) Thiamine [Mass/volume] in Blood

105

2.29

5.68

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

153

2.04

5.61

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.70

5.61

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.07

5.57

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

281

1.73

5.38

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

177

611

1.48

5.35

4.8

3.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

107

328

1.67

5.34

1.3

38.25

38.68

0.04

237

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.56

5.32

1.2

1.0

88.78

48.95

u/l

0.47

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

8.77

5.23

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.46

5.21

1.6

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.49

5.20

1.1

5.75

8.52

u/ml

0.39

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1029

6111

0.86

5.14

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4303

20477

1.08

5.12

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9651

47192

1.06

5.11

3.7

2.7

—

(40768806) Pleura Pathology biopsy report

379

1499

1.30

5.09

1.6

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.31

5.08

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

4.51

5.02

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

112

2.15

4.95

1.3

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

139

464

1.53

4.95

1.9

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.95

4.93

7.5

11.5

40.17

43.93

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

6.65

4.88

1.3

1.1

1.55

1.22

mg/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

566

1.47

4.84

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

114

2.11

4.76

1.4

1.2

56.20

48.43

mg/l

0.37

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

158

548

1.48

4.73

1.1

—

(1616796) Gas panel - Central venous blood

879

3836

1.18

4.68

3.6

3.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.94

4.68

1.5

—

(3044007) Cell count panel - Peritoneal fluid

118

385

1.57

4.67

2.7

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

469

2957

0.81

4.62

2.2

1.7

1.71

1.78

mmol/l

0.71

457

2892

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.31

4.62

1.7

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.33

4.59

1.1

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.16

4.56

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.44

4.50

1.5

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.23

4.43

1.1

1.0

0.96

1.17

u/ml

0.14

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.35

4.42

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.35

4.42

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

157

1.89

4.42

3.2

2.5

20.25

23.18

mg/l

0.87

147

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

154

1.89

4.37

3.2

2.5

—

(3010421) pH of Blood

828

4929

0.86

4.34

4.2

3.6

7.42

0.65

697

4650

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.61

4.30

11.6

4.0

—

(3050794) Legionella sp Ab [Presence] in Serum

123

2.00

4.27

1.1

—

(3045788) Cell count panel - Pleural fluid

326

1300

1.28

4.20

1.5

—

(3032641) Amino acids panel - Urine

4.77

4.19

1.1

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.31

4.16

1.1

1.3

15.96

16.55

pmol/l

0.07

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.11

4.13

1.0

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

116

389

1.53

4.13

1.4

1.2

3.34

3.73

mmol/l

0.69

103

358

(40759632) Porphyrins [Mass/mass] in Stool

7.31

4.06

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.56

4.02

1.2

1.1

0.03

0.89

mg/l

0.52

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.74

4.01

1.5

1.3

534.60

491.18

nmol/l

0.10

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.15

3.99

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.23

3.98

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.36

3.97

1.1

2.25

4.40

u/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

202

1.72

3.91

1.1

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.20

3.87

1.1

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

2.56

3.87

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

100

2.05

3.83

3.8

2.1

11.98

16.30

0.50

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1100

6357

0.88

3.81

1.4

1.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.39

3.80

2.0

1.6

197.14

188.09

ng/l

0.23

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.06

3.79

1.1

10.41

12.54

u/l

0.26

(3020874) Milk IgE Ab [Units/volume] in Serum

284

1133

1.28

3.71

1.1

1.03

2.16

u/ml

0.59

111

328

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.27

3.69

1.2

1.1

3.62

2.36

0.54

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.35

3.68

3.8

3.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

161

1.78

3.62

1.6

94.53

110.76

ug/l

0.54

129

(40761995) Spermatozoa Progressive [#/volume] in Semen

683

0.66

3.61

2.5

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

683

0.66

3.61

5.0

6.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.02

3.61

1.4

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1038

5994

0.88

3.58

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1037

5988

0.88

3.58

1.4

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.69

3.51

1.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.15

3.50

1.8

1.2

1.44

2.23

mmol/24h

1.09

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1033

5956

0.88

3.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1038

5980

0.88

3.46

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.62

3.43

1.0

1.1

276.57

271.42

nmol/l

0.03

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

1.88

3.37

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

215

1416

0.78

3.24

1.6

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

191

1.66

3.20

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.40

3.20

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

259

1665

0.79

3.20

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.07

3.17

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2101

11623

0.92

3.16

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

160

1091

0.75

3.14

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

127

1.81

3.13

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

202

791

1.31

3.10

1.2

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.12

3.08

1.0

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.32

3.08

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.84

3.08

7.0

3.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

102

357

1.46

3.07

2.6

2.2

157.62

93.66

ng/l

1.00

163

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1031

5885

0.89

2.99

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.63

2.98

6.8

5.5

1.02

1.70

mg/l

0.78

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

137

1.75

2.97

1.2

1.1

21.21

19.95

u/l

0.15

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.23

2.89

1.8

1.5

0.20

0.38

u/l

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

214

1.58

2.84

1.0

84.42

77.43

ug/l

0.62

180

(40761539) Cells [Type] in Urine sediment by Light microscopy

109

395

1.41

2.77

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

244

1.53

2.77

1.6

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.05

2.76

1.1

0.01

4.18

u/ml

1.99

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

151

1016

0.76

2.75

1.6

1.4

—

(3042301) Urate [Moles/volume] in Synovial fluid

3.23

2.75

1.1

1.0

416.40

353.18

umol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

188

1.61

2.73

1.7

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

210

843

1.28

2.73

1.3

1.4

5.74

5.54

mmol/l

1.56

193

795

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.11

2.72

1.1

1.0

1075.00

1243.75

titre

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

107

1.82

2.71

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.64

2.69

1.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

5.97

2.67

1.4

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.97

2.67

1.0

307.71

298.00

nmol/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.52

2.65

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.52

2.65

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.52

2.65

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.52

2.65

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.52

2.65

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.52

2.65

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.85

2.57

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.96

2.50

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

145

1.66

2.49

1.6

1.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

118

1.73

2.48

1.2

834.47

76.51

u/l

0.52

(3013166) Neutrophils/100 leukocytes in Synovial fluid

113

422

1.37

2.46

1.3

49.72

56.80

1.16

363

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

154

1016

0.77

2.46

1.6

1.4

—

(3000285) Sodium [Moles/volume] in Blood

154

1.63

2.43

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

269

1129

1.22

2.41

1.0

1.1

1.21

4.33

u/ml

0.67

264

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.98

2.41

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

139

1.66

2.39

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

6.14

2.38

1.0

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

112

1.74

2.38

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.09

2.32

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

319

1367

1.19

2.32

1.4

1.3

6.30

6.08

mmol/l

0.60

294

1261

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

525

2344

1.15

2.29

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

813

3731

1.12

2.29

1.7

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

110

1.72

2.26

1.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

2.25

2.24

1.1

1.0

0.75

0.06

u/ml

—

(40767503) Oxygen content in Capillary blood by calculation

672

3850

0.89

2.19

2.8

2.3

16.70

16.61

0.22

402

1777

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

167

1.56

2.18

1.9

1.7

1.62

1.84

mg/l

0.42

137

(3013293) Extractable nuclear Ab [Presence] in Serum

200

1.51

2.17

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

683

3116

1.12

2.15

1.1

—

(3002619) Bacteria identified in Specimen by Culture

289

1.42

2.15

1.5

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

5.11

2.14

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.56

2.09

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

681

3117

1.12

2.05

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

338

0.65

2.04

3.0

14.65

14.80

ml/dl

0.14

321

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.32

2.02

1.1

1.0

0.87

0.06

u/ml

—

(3015183) Erythrocyte sedimentation rate

229

968

1.21

1.98

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

132

524

1.29

1.98

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

644

3671

0.90

1.96

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

855

4802

0.91

1.95

1.5

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.38

1.94

1.3

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

117

460

1.30

1.90

6.3

5.5

24.35

25.05

mmol/l

1.03

110

405

(40765089) Chromosome analysis panel - Blood by G-banded

160

655

1.25

1.89

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.69

1.88

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

250

1.41

1.87

1.3

1.9

2.63

4.54

ug/l

0.47

164

(3007700) Barley IgE Ab [Units/volume] in Serum

1.92

1.83

1.0

0.97

0.17

u/ml

—

(3035880) pH of Pleural fluid

183

765

1.22

1.80

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.81

1.76

1.0

1.17

0.26

u/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

614

2824

1.11

1.75

1.4

1.3

3.35

4.06

ug/l

0.85

550

2568

(3015350) Toxocara sp Ab [Presence] in Serum

3.25

1.73

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

977

5417

0.92

1.71

1.8

—

(3016750) Collection duration of Urine

198

840

1.21

1.70

2.2

1.9

495.45

502.25

min

0.47

177

564

(3034614) HLA Ag [Interpretation]

2.36

1.69

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

217

931

1.19

1.66

3.0

2.8

60.27

46.90

mg/l

0.29

146

643

(3038071) Oxygen [Partial pressure] in Mixed venous blood

252

1.38

1.66

9.0

5.9

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

2.05

1.66

1.0

0.89

0.03

u/ml

—

(3007147) Virus identified in Stool by Electron microscopy

4.26

1.64

1.0

—

(3003577) Lead [Moles/volume] in Blood

142

1.51

1.64

1.1

1.6

0.12

0.24

umol/l

2.10

(3024316) Viscosity of Plasma

1.75

1.63

1.3

1.9

1.70

1.97

mpas

0.68

(3025130) Human papilloma virus identified in Specimen

523

2398

1.12

1.61

1.7

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.41

1.60

1.2

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

197

1.40

1.47

2.9

2.5

—

(40758358) Immune stain study

1.89

1.46

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.84

1.44

1.1

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.73

1.38

1.0

1.1

—

(3039000) Anion gap in Blood

602

2809

1.10

1.37

7.9

5.8

11.49

11.34

mmol/l

0.50

542

2487

(3018572) Chloride [Moles/volume] in Blood

602

2810

1.10

1.36

7.9

5.8

105.00

105.02

mmol/l

0.04

543

2488

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

107

1.53

1.35

1.3

1.2

98.68

111.10

ug/l

0.20

(3041184) Isoniazid [Presence] in Urine

2.79

1.33

2.7

2.1

—

(3022670) pH of Venous cord blood

1.86

1.33

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.20

1.32

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

3.20

1.32

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.94

1.29

1.0

1.1

4.56

4.84

mmol/l

0.16

(3021162) Amylase [Enzymatic activity/volume] in Specimen

225

1.34

1.27

2.6

3.0

1437.54

1729.94

u/l

0.11

206

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

378

1.26

1.27

1.1

60.61

63.28

u/ml

0.12

366

(3046861) Legionella sp Ag [Presence] in Urine

111

0.55

1.20

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.63

1.16

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

253

1139

1.14

1.2

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.19

1.11

2.3

2.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.47

1.06

4.9

4.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

242

1.29

1.05

1.4

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

230

1.29

1.01

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.11

1.01

1.1

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.53

0.98

1.3

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.51

0.97

1.4

1.3

1.83

1.46

mg/l

0.75

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

146

642

1.16

0.96

2.0

2.2

108.95

130.84

ug/min

0.13

123

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

2.36

0.96

1.0

1.3

40.67

20.24

ng/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

197

1142

0.88

0.96

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.47

0.94

1.0

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

306

1.24

0.94

8.6

6.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

358

2005

0.91

0.93

2.2

32.94

32.75

0.38

353

1989

(40768793) Breast Pathology biopsy report

697

3338

1.07

0.93

1.4

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

135

594

1.16

0.90

2.5

3.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

294

1.24

0.90

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

124

542

1.17

0.90

1.5

1.8

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.70

0.87

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

513

2438

1.08

0.87

1.3

7.13

6.94

mmol/l

0.76

449

2173

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.86

0.86

1.6

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

231

1060

1.11

0.84

1.0

0.62

0.76

u/ml

0.23

219

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.46

0.83

3.0

1.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.32

0.79

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.32

0.79

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

117

517

1.16

0.77

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.47

0.75

1.1

1.5

1.18

1.13

u/field

0.08

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.88

0.75

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

316

1486

1.09

0.73

1.6

1.5

33.21

31.60

0.32

208

921

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.44

0.72

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

355

1682

1.08

0.70

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

1096

0.90

0.67

1.5

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.56

0.65

1.0

180.17

166.02

g/l

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.64

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

113

1.31

0.64

1.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

186

1.24

0.63

1.4

32.61

24.08

0.76

142

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.61

0.63

1.7

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

275

0.82

0.61

1.2

—

(3008607) Semen analysis panel

164

1.25

0.61

1.2

—

(36303858) Crystals [Presence] in Urine

1.57

0.61

1.1

1.0

—

(3012565) Volume of 24 hour Urine

162

916

0.90

0.60

2.1

2.2

2092.16

2000.74

0.36

149

834

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.56

0.57

4.2

5.8

0.16

0.22

mmol/l

0.48

(3003157) Bacteria [#/volume] in Mother's milk

1.60

0.56

2.9

5.6

—

(3019977) pH of Arterial blood

185

863

1.10

0.56

2.8

2.4

7.42

7.43

0.37

356

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.30

0.54

1.1

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2660

13303

1.02

0.54

4.2

3.7

1.23

1.22

mmol/l

0.75

2453

11316

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

145

670

1.11

0.54

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

413

1993

1.06

0.53

4.0

6.1

7.20

7.10

mmol/l

0.18

317

1639

(46235168) Fasting glucose [Moles/volume] in Blood

233

1.19

0.53

2.0

2.2

7.22

7.01

mmol/l

0.15

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

414

1.12

0.47

1.2

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.43

0.0

1.1

—

5.50

—

(3041806) Other cells [#/volume] in Blood by Manual count

180

991

0.93

0.42

1.6

1.4

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

248

1191

1.07

0.41

2.8

2.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

495

0.90

0.41

1.4

3.29

2.46

0.44

423

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.50

0.41

1.4

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

256

0.86

0.40

3.7

4.6

43.81

50.95

ug/min

0.40

211

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.39

0.40

1.0

—

mmol/l

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.30

0.40

1.1

1.0

20.08

21.65

0.65

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.30

0.40

1.1

1.0

8.09

8.69

0.37

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.30

0.40

1.1

1.0

37.94

36.32

0.87

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

144

0.82

0.37

1.2

1.4

74.20

70.06

0.28

117

(3000919) Neutrophils/100 leukocytes in Pleural fluid

426

0.90

0.36

1.3

25.70

22.34

0.46

388

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

348

1697

1.05

0.36

1.3

1.4

8.80

7.87

mmol/l

3.89

337

1633

(3036525) Urea [Moles/time] in 24 hour Urine

102

1.20

0.31

2.5

2.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

110

521

1.08

0.30

1.5

1.4

57.58

62.47

0.72

441

(3013762) Body weight Measured

1.31

0.29

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.28

0.27

1.1

7.72

8.77

mmol/l

1.23

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.67

0.27

1.4

1.2

0.00

0.63

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

332

1.09

0.27

1.7

2.7

7.96

7.22

mmol/l

0.62

165

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.71

0.25

1.2

1.3

—

(4281824) Cell count and differential, peritoneal fluid

333

1764

0.97

0.24

1.3

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.35

0.24

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.35

0.24

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.28

0.23

1.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

152

0.87

0.22

1.0

9.44

9.04

mu/l

0.10

120

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

455

1.07

0.22

3.1

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

455

1.07

0.22

3.1

2.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.28

0.21

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.83

0.21

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.23

0.20

1.2

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.23

0.20

3.3

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

237

1253

0.97

0.18

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1388

7185

0.99

0.17

1.5

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

121

0.89

0.16

1.1

1.7

1.85

0.65

0.53

(3042010) Triglyceride [Moles/volume] in Pleural fluid

179

0.91

0.15

1.3

1.2

2.03

1.54

mmol/l

0.15

107

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

319

1592

1.02

0.15

1.5

1.6

8.18

7.54

mmol/l

4.49

304

1533

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

275

1.06

0.13

2.5

2.4

14.50

30.58

mg/l

1.77

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

135

0.91

0.13

4.1

1.9

14.53

19.43

0.50

(3041918) Cholesterol [Moles/volume] in Pleural fluid

247

1.06

0.11

1.2

1.46

1.66

mmol/l

0.40

142

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

118

1.08

0.10

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

148

1.07

0.09

8.0

6.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.16

0.09

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

101

0.91

0.09

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

220

1146

0.98

0.08

1.4

28.16

32.99

nmol/l

1.74

196

1071

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8400

42864

1.00

0.07

1.7

1.6

1.45

1.36

mmol/l

11.64

7431

35070

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

191

0.96

0.04

7.5

6.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

154

798

0.99

0.04

1.6

1.4

4.32

4.25

0.02

205

(3001019) Free T4 and TSH panel - Serum or Plasma

2053

10471

1.00

0.03

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

219

1.03

0.03

1.2

20.39

20.44

mmol/l

0.03

181

(3004959) Base excess in Arterial cord blood by calculation

143

1.04

0.03

1.0

-0.83

-1.91

mmol/l

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

143

0.97

0.02

1.0

2.70

3.66

kpa

1.81

120

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

225

1.02

0.02

1.2

1.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

164

1.03

0.02

1.2

1.1

17.00

17.69

g/l

0.15

147

(3000012) Reticulocyte production index

434

2228

1.00

0.02

2.0

2.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

154

1.03

0.02

3.5

2.0

52.43

56.68

0.28

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

343

1.01

0.01

1.4

1.2

—

(3004451) EKG impression Narrative

151

776

0.99

0.00

1.3

1.2

—

(3001729) Color of Synovial fluid

135

1.02

0.00

1.2

1.6

—

(4212803) Bone marrow aspirate examination

124

0.99

0.00

1.1

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

146

1.02

0.00

1.0

7.73

7.36

kpa

0.50

124

(3051101) Glucose [Moles/volume] in Cord blood

305

1.01

0.00

4.6

6.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

294

1.01

0.00

1.3

1.2

78.67

35.72

mg/l

0.23

217

(3006598) pH of Arterial cord blood

147

1.01

0.00

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

232

0.99

0.00

1.5

1.4

11.95

10.43

0.16

134

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

12.46

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.02

-0.00

1.0

0.06

0.07

u/ml

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.02

-0.00

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.91

-0.00

1.0

1.1

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.02

-0.00

1.4

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI – Medical observation and evaluation for suspected diseases and conditions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Medical observation and evaluation for suspected diseases and conditions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Medical observation and evaluation for suspected diseases and conditions (Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints